<!DOCTYPE html>
<html lang="en">
<head>
    <title>
Epstein&#x2013;Barr virus - Wikipedia - linksfor.dev(s)    </title>
    <meta charset="utf-8">
    <link rel="alternate" type="application/rss+xml" title="Linksfor.dev(s) feed" href="https://linksfor.dev/feed.rss" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <meta name="google" value="notranslate">
    <link rel="stylesheet" type="text/css" href="/style.css" />
    <link rel="shortcut icon" href="/favicon.ico" type="image/x-icon">
    <link rel="icon" href="/favicon.ico" type="image/x-icon">
    <meta property="og:title" content="Epstein&#x2013;Barr virus - Wikipedia - linksfor.dev(s)"/>
    <meta property="og:description" content="Human gammaherpesvirus 4"/>
    <meta property="og:type" content="website"/>
    <meta property="og:url" content="https://en.wikipedia.org/wiki/Epstein%E2%80%93Barr_virus"/>

<meta property="og:site_name" content="linksfor.dev(s)" />
</head>
<body>
    <div class="devring" style="background: #222">
        <div style="text-align:center">Explore other dev related sites in this ring. If you would like to join this ring <a href="https://devring.club">click here</a>.</div>
        <div class="grid">
            <div style="display: grid; grid-template-columns: .5fr 1fr 1fr 1fr; text-align: center;">
                <span class="devring-title"><a href="https://devring.club/">devring.club</a></span>
                <a href="https://devring.club/sites/1/prev" class="devring-previous">Previous</a>
                <a href="https://devring.club/random" class="devring-random">Random</a>
                <a href="https://devring.club/sites/1/next" class="devring-next">Next</a>
            </div>
        </div>
    </div>
    <div class="grid">
        <h1>
<a href="/" style="color:inherit">linksfor.dev(s)</a>
        </h1>
        <title>linksfor.dev(s) - Epstein&#x2013;Barr virus - Wikipedia</title>
<div class="readable">
        <h1>Epstein&#x2013;Barr virus - Wikipedia</h1>
            <div>Reading time: 29-37 minutes</div>
        <div>Posted here: 10 Aug 2019</div>
        <p><a href="https://en.wikipedia.org/wiki/Epstein%E2%80%93Barr_virus">https://en.wikipedia.org/wiki/Epstein%E2%80%93Barr_virus</a></p>
        <hr/>
<div id="readability-page-1" class="page"><div id="mw-content-text" lang="en" dir="ltr"><div>
<table>

<tbody><tr>
<th colspan="2"><i>Human gammaherpesvirus 4</i>
</th></tr>
<tr>
<td colspan="2"><a href="https://en.wikipedia.org/wiki/File:Epstein_Barr_Virus_virions_EM_10.1371_journal.pbio.0030430.g001-L.JPG" title="Electron microscopic image of two Epstein-Barr virus virions (viral particles) showing round capsids (protein-encased genetic material) loosely surrounded by the membrane envelope"><img alt="Electron microscopic image of two Epstein-Barr virus virions (viral particles) showing round capsids (protein-encased genetic material) loosely surrounded by the membrane envelope" src="https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Epstein_Barr_Virus_virions_EM_10.1371_journal.pbio.0030430.g001-L.JPG/220px-Epstein_Barr_Virus_virions_EM_10.1371_journal.pbio.0030430.g001-L.JPG" decoding="async" width="220" height="157" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/07/Epstein_Barr_Virus_virions_EM_10.1371_journal.pbio.0030430.g001-L.JPG/330px-Epstein_Barr_Virus_virions_EM_10.1371_journal.pbio.0030430.g001-L.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/07/Epstein_Barr_Virus_virions_EM_10.1371_journal.pbio.0030430.g001-L.JPG/440px-Epstein_Barr_Virus_virions_EM_10.1371_journal.pbio.0030430.g001-L.JPG 2x" data-file-width="1370" data-file-height="976"></a>
</td></tr>
<tr>
<td colspan="2"><a href="https://en.wikipedia.org/wiki/Electron_micrograph" title="Electron micrograph">Electron micrograph</a> of two Epstein–Barr virions (viral particles) showing round <a href="https://en.wikipedia.org/wiki/Capsid" title="Capsid">capsids</a> loosely surrounded by the membrane <a href="https://en.wikipedia.org/wiki/Viral_envelope" title="Viral envelope">envelope</a>
</td></tr>





<tr>
<th colspan="2"><a href="https://en.wikipedia.org/wiki/Virus_classification" title="Virus classification">Virus classification</a> <span><a href="https://en.wikipedia.org/wiki/Template:Taxonomy/Lymphocryptovirus" title="e"><img alt="e" src="https://upload.wikimedia.org/wikipedia/commons/7/74/Red_Pencil_Icon.png" decoding="async" width="16" height="16" data-file-width="16" data-file-height="16"></a></span>
</th></tr>
<tr>
<td>(unranked):
</td>
<td><a href="https://en.wikipedia.org/wiki/Virus" title="Virus">Virus</a>
</td></tr>
<tr>
<td>Phylum:
</td>
<td><a href="https://en.wikipedia.org/wiki/Incertae_sedis" title="Incertae sedis"><i>incertae sedis</i></a>
</td></tr>
<tr>
<td>Class:
</td>
<td><a href="https://en.wikipedia.org/wiki/Incertae_sedis" title="Incertae sedis"><i>incertae sedis</i></a>
</td></tr>
<tr>
<td>Order:
</td>
<td><a href="https://en.wikipedia.org/wiki/Herpesvirales" title="Herpesvirales"><i>Herpesvirales</i></a>
</td></tr>
<tr>
<td>Family:
</td>
<td><a href="https://en.wikipedia.org/wiki/Herpesviridae" title="Herpesviridae"><i>Herpesviridae</i></a>
</td></tr>
<tr>
<td>Genus:
</td>
<td><a href="https://en.wikipedia.org/wiki/Lymphocryptovirus" title="Lymphocryptovirus"><i>Lymphocryptovirus</i></a>
</td></tr>
























































































<tr>
<td>Species:
</td>
<td><p><i><b>Human gammaherpesvirus 4</b></i></p>
</td></tr>










































<tr>
<th colspan="2"><a href="https://en.wikipedia.org/wiki/Synonym_(taxonomy)" title="Synonym (taxonomy)">Synonyms</a><sup id="cite_ref-ICTV10_1-0"><a href="#cite_note-ICTV10-1">[1]</a></sup>
</th></tr>
<tr>
<td colspan="2">
<ul><li><i>Epstein-Barr virus</i></li>
<li><i>Human herpesvirus 4</i></li>
<li><i>HHV-4</i></li>
<li><i>EBV</i></li>
<li><i>EPV</i> (rarely used)</li></ul>
</td></tr>

</tbody></table>
<p>The <b>Epstein–Barr virus</b> (<b>EBV</b>, sometimes abbreviated as <b>EPV</b>), formally called <i><b>Human gammaherpesvirus 4</b></i>, is one of the nine known <a href="https://en.wikipedia.org/wiki/Herpesviridae#Human_herpesvirus_types" title="Herpesviridae">human herpesvirus types</a> in the <a href="https://en.wikipedia.org/wiki/Herpesviridae" title="Herpesviridae">herpes family</a>, and is one of the most common viruses in humans.
</p><p>It is best known as the cause of <a href="https://en.wikipedia.org/wiki/Infectious_mononucleosis" title="Infectious mononucleosis">infectious mononucleosis</a> ("mono" or "glandular fever"). It is also associated with various non-malignant, <a href="https://en.wikipedia.org/wiki/Premalignant" title="Premalignant">premalignant</a>, and malignant <a href="https://en.wikipedia.org/wiki/Epstein%E2%80%93Barr_virus-associated_lymphoproliferative_diseases" title="Epstein–Barr virus-associated lymphoproliferative diseases">Epstein–Barr virus-associated lymphoproliferative diseases</a> such as <a href="https://en.wikipedia.org/wiki/Epstein-Barr_virus-associated_lymphoproliferative_diseases#Epstein%E2%80%93Barr_virus-positive_Burkitt_lymphoma" title="Epstein-Barr virus-associated lymphoproliferative diseases">Burkitt lymphoma</a>, <a href="https://en.wikipedia.org/wiki/Epstein%E2%80%93Barr_virus-associated_lymphoproliferative_diseases#Epstein%E2%80%93Barr_virus-related_hemophagocytic_lymphohistiocytosis" title="Epstein–Barr virus-associated lymphoproliferative diseases">hemophagocytic lymphohistiocytosis</a>,<sup id="cite_ref-pmid29885408_2-0"><a href="#cite_note-pmid29885408-2">[2]</a></sup> and <a href="https://en.wikipedia.org/wiki/Epstein-Barr_virus-associated_lymphoproliferative_diseases#Epstein%E2%80%93Barr_virus-positive_Hodgkin_lymphoma" title="Epstein-Barr virus-associated lymphoproliferative diseases">Hodgkin's lymphoma</a>; non-lymphoid malignancies such as <a href="https://en.wikipedia.org/wiki/Gastric_cancer" title="Gastric cancer">gastric cancer</a> and <a href="https://en.wikipedia.org/wiki/Nasopharyngeal_carcinoma" title="Nasopharyngeal carcinoma">nasopharyngeal carcinoma</a>; and conditions associated with <a href="https://en.wikipedia.org/wiki/Human_immunodeficiency_virus" title="Human immunodeficiency virus">human immunodeficiency virus</a> such as <a href="https://en.wikipedia.org/wiki/Hairy_leukoplakia" title="Hairy leukoplakia">hairy leukoplakia</a> and <a href="https://en.wikipedia.org/wiki/Central_nervous_system" title="Central nervous system">central nervous system</a> <a href="https://en.wikipedia.org/wiki/Lymphoma" title="Lymphoma">lymphomas</a>.<sup id="cite_ref-pmid19373526_3-0"><a href="#cite_note-pmid19373526-3">[3]</a></sup><sup id="cite_ref-Cherry-Peppers_2003_4-0"><a href="#cite_note-Cherry-Peppers_2003-4">[4]</a></sup> The virus is also associated with the childhood disorders of <a href="https://en.wikipedia.org/wiki/Alice_in_Wonderland_syndrome" title="Alice in Wonderland syndrome">Alice in Wonderland syndrome</a><sup id="cite_ref-pmid28116304_5-0"><a href="#cite_note-pmid28116304-5">[5]</a></sup> and <a href="https://en.wikipedia.org/wiki/Acute_cerebellar_ataxia_of_childhood" title="Acute cerebellar ataxia of childhood">acute cerebellar ataxia</a><sup id="cite_ref-pmid14552515_6-0"><a href="#cite_note-pmid14552515-6">[6]</a></sup> and, based on some evidence, higher risks of developing certain <a href="https://en.wikipedia.org/wiki/Autoimmune_disease" title="Autoimmune disease">autoimmune diseases</a>,<sup id="cite_ref-pmid19028369_7-0"><a href="#cite_note-pmid19028369-7">[7]</a></sup> especially <a href="https://en.wikipedia.org/wiki/Dermatomyositis" title="Dermatomyositis">dermatomyositis</a>, <a href="https://en.wikipedia.org/wiki/Systemic_lupus_erythematosus" title="Systemic lupus erythematosus">systemic lupus erythematosus</a>, <a href="https://en.wikipedia.org/wiki/Rheumatoid_arthritis" title="Rheumatoid arthritis">rheumatoid arthritis</a>, <a href="https://en.wikipedia.org/wiki/Sj%C3%B6gren%27s_syndrome" title="Sjögren's syndrome">Sjögren's syndrome</a>,<sup id="cite_ref-pmid21871974_8-0"><a href="#cite_note-pmid21871974-8">[8]</a></sup><sup id="cite_ref-pmid22312480_9-0"><a href="#cite_note-pmid22312480-9">[9]</a></sup> and <a href="https://en.wikipedia.org/wiki/Multiple_sclerosis" title="Multiple sclerosis">multiple sclerosis</a>.<sup id="cite_ref-pmid20369303_10-0"><a href="#cite_note-pmid20369303-10">[10]</a></sup><sup id="cite_ref-Moreno_11-0"><a href="#cite_note-Moreno-11">[11]</a></sup><sup id="cite_ref-12"><a href="#cite_note-12">[12]</a></sup> About 200,000 cancer cases per year are thought to be attributable to EBV.<sup id="cite_ref-200000_cancers_13-0"><a href="#cite_note-200000_cancers-13">[13]</a></sup><sup id="cite_ref-14"><a href="#cite_note-14">[14]</a></sup>
</p><p>Infection with EBV occurs by the oral transfer of <a href="https://en.wikipedia.org/wiki/Saliva" title="Saliva">saliva</a><sup id="cite_ref-Reactivation_of_Epstein-Barr_Virus_15-0"><a href="#cite_note-Reactivation_of_Epstein-Barr_Virus-15">[15]</a></sup> and genital secretions.
</p><p>Most people become infected with EBV and gain <a href="https://en.wikipedia.org/wiki/Adaptive_immunity" title="Adaptive immunity">adaptive immunity</a>. In the United States, about half of all five-year-old children and about 90% of adults have evidence of previous infection.<sup id="cite_ref-CDC_–_Epstein–Barr_Virus_and_Infectious_Mononucleosis_16-0"><a href="#cite_note-CDC_–_Epstein–Barr_Virus_and_Infectious_Mononucleosis-16">[16]</a></sup> Infants become susceptible to EBV as soon as <a href="https://en.wikipedia.org/wiki/Passive_immunity#Naturally_acquired_passive_immunity" title="Passive immunity">maternal antibody protection</a> disappears. Many children become infected with EBV, and these infections usually cause no symptoms or are indistinguishable from the other mild, brief illnesses of childhood. In the United States and other developed countries, many people are not infected with EBV in their childhood years.<sup id="cite_ref-17"><a href="#cite_note-17">[17]</a></sup> When infection with EBV occurs during adolescence, it causes <a href="https://en.wikipedia.org/wiki/Infectious_mononucleosis" title="Infectious mononucleosis">infectious mononucleosis</a> 35 to 50% of the time.<sup id="cite_ref-18"><a href="#cite_note-18">[18]</a></sup>
</p><p>EBV infects <a href="https://en.wikipedia.org/wiki/B_cells" title="B cells">B cells</a> of the immune system and <a href="https://en.wikipedia.org/wiki/Epithelial_cells" title="Epithelial cells">epithelial cells</a>. Once EBV's initial <a href="https://en.wikipedia.org/wiki/Lytic" title="Lytic">lytic</a> infection is brought under control, EBV <a href="https://en.wikipedia.org/wiki/Virus_latency" title="Virus latency">latency</a> persists in the individual's B cells for the rest of their life.<sup id="cite_ref-Reactivation_of_Epstein-Barr_Virus_15-1"><a href="#cite_note-Reactivation_of_Epstein-Barr_Virus-15">[15]</a></sup><sup id="cite_ref-19"><a href="#cite_note-19">[19]</a></sup>
</p>


<h2><span id="Signs_and_symptoms">Signs and symptoms</span><span><span>[</span><a href="https://en.wikipedia.org/w/index.php?title=Epstein%E2%80%93Barr_virus&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a><span>]</span></span></h2>

<p>Children who contract EBV exhibit few symptoms or may even appear asymptomatic, but when EBV is contracted as an adolescent or adult, it may cause <a href="https://en.wikipedia.org/wiki/Fatigue_(medical)" title="Fatigue (medical)">fatigue</a>, <a href="https://en.wikipedia.org/wiki/Fever" title="Fever">fever</a>, <a href="https://en.wikipedia.org/wiki/Pharyngitis" title="Pharyngitis">inflamed throat</a>, <a href="https://en.wikipedia.org/wiki/Lymphadenopathy" title="Lymphadenopathy">swollen</a> <a href="https://en.wikipedia.org/wiki/Lymph_nodes" title="Lymph nodes">lymph nodes</a> in the neck, <a href="https://en.wikipedia.org/wiki/Splenomegaly" title="Splenomegaly">enlarged spleen</a>, <a href="https://en.wikipedia.org/wiki/Hepatomegaly" title="Hepatomegaly">swollen liver</a>, or rash.<sup id="cite_ref-20"><a href="#cite_note-20">[20]</a></sup>
</p>
<h2><span id="Virology">Virology</span><span><span>[</span><a href="https://en.wikipedia.org/w/index.php?title=Epstein%E2%80%93Barr_virus&amp;action=edit&amp;section=2" title="Edit section: Virology">edit</a><span>]</span></span></h2>
<div><div><p><a href="https://en.wikipedia.org/wiki/File:Viral_Tegument.svg"><img alt="" src="https://upload.wikimedia.org/wikipedia/commons/thumb/b/bb/Viral_Tegument.svg/300px-Viral_Tegument.svg.png" decoding="async" width="300" height="195" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/bb/Viral_Tegument.svg/450px-Viral_Tegument.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/bb/Viral_Tegument.svg/600px-Viral_Tegument.svg.png 2x" data-file-width="340" data-file-height="221"></a></p><div><p>Simplified diagram of the structure of EBV</p></div></div></div>
<h3><span id="Structure_and_genome">Structure and genome</span><span><span>[</span><a href="https://en.wikipedia.org/w/index.php?title=Epstein%E2%80%93Barr_virus&amp;action=edit&amp;section=3" title="Edit section: Structure and genome">edit</a><span>]</span></span></h3>
<p>The <a href="https://en.wikipedia.org/wiki/Virion" title="Virion">virus</a> is about 122–180 <a href="https://en.wikipedia.org/wiki/Nanometer" title="Nanometer">nm</a> in diameter and is composed of <a href="https://en.wikipedia.org/wiki/Double-stranded_DNA" title="Double-stranded DNA">a double helix</a> of <a href="https://en.wikipedia.org/wiki/Deoxyribonucleic_acid" title="Deoxyribonucleic acid">deoxyribonucleic acid</a> (DNA) which contains about 172,000 <a href="https://en.wikipedia.org/wiki/Base_pairs" title="Base pairs">base pairs</a> and 85 <a href="https://en.wikipedia.org/wiki/Gene" title="Gene">genes</a>.<sup id="cite_ref-Reactivation_of_Epstein-Barr_Virus_15-2"><a href="#cite_note-Reactivation_of_Epstein-Barr_Virus-15">[15]</a></sup> The DNA is surrounded by a protein <a href="https://en.wikipedia.org/wiki/Nucleocapsid" title="Nucleocapsid">nucleocapsid</a>, which is surrounded by a <a href="https://en.wikipedia.org/wiki/Viral_tegument" title="Viral tegument">tegument</a> made of protein, which in turn is surrounded by an  <a href="https://en.wikipedia.org/wiki/Viral_envelope" title="Viral envelope">envelope</a> containing both <a href="https://en.wikipedia.org/wiki/Lipids" title="Lipids">lipids</a><sup id="cite_ref-Progress_and_Problems_in_Understanding_21-0"><a href="#cite_note-Progress_and_Problems_in_Understanding-21">[21]</a></sup> and surface projections of <a href="https://en.wikipedia.org/wiki/Glycoproteins" title="Glycoproteins">glycoproteins</a>, which are essential to <a href="#Entry_to_the_cell">infection of the host cell</a>.<sup id="cite_ref-Progress_and_Problems_in_Understanding_21-1"><a href="#cite_note-Progress_and_Problems_in_Understanding-21">[21]</a></sup>
</p>
<h3><span id="Tropism">Tropism</span><span><span>[</span><a href="https://en.wikipedia.org/w/index.php?title=Epstein%E2%80%93Barr_virus&amp;action=edit&amp;section=4" title="Edit section: Tropism">edit</a><span>]</span></span></h3>
<p>The term <a href="https://en.wikipedia.org/wiki/Viral_tropism" title="Viral tropism">viral tropism</a> refers to which cell types that EBV infects. EBV can infect different cell types, including <a href="https://en.wikipedia.org/wiki/B_cells" title="B cells">B cells</a> and <a href="https://en.wikipedia.org/wiki/Epithelial_cells" title="Epithelial cells">epithelial cells</a>.<sup id="cite_ref-22"><a href="#cite_note-22">[22]</a></sup>
</p><p>The viral three-part glycoprotein complexes of <a href="https://en.wikipedia.org/w/index.php?title=GHgL_gp42&amp;action=edit&amp;redlink=1" title="GHgL gp42 (page does not exist)">gHgL gp42</a> mediate B cell membrane fusion; although the two-part complexes of gHgL mediate epithelial cell membrane fusion. EBV that are made in the B cells have low numbers of gHgLgp42 complexes, because these three-part complexes interact with <a href="https://en.wikipedia.org/wiki/Human_leukocyte_antigen" title="Human leukocyte antigen">Human-leukocyte-antigen</a> <a href="https://en.wikipedia.org/wiki/MHC_Class_II" title="MHC Class II">class II</a> molecules present in B cells in the endoplasmic reticulum and are degraded. In contrast, EBV from epithelial cells are rich in the three-part complexes because these cells do not normally contain HLA class II molecules. As a consequence, EBV made from B cells are more infectious to epithelial cells, and EBV made from epithelial cells are more infectious to B cells.  Viruses lacking the <a href="https://en.wikipedia.org/w/index.php?title=Gp42&amp;action=edit&amp;redlink=1" title="Gp42 (page does not exist)">gp42</a> portion are able to bind to human B cells, but unable to infect.<sup id="cite_ref-23"><a href="#cite_note-23">[23]</a></sup>
</p>
<h3><span id="Replication_cycle">Replication cycle</span><span><span>[</span><a href="https://en.wikipedia.org/w/index.php?title=Epstein%E2%80%93Barr_virus&amp;action=edit&amp;section=5" title="Edit section: Replication cycle">edit</a><span>]</span></span></h3>
<div><div><p><a href="https://en.wikipedia.org/wiki/File:EBV_infection_cycle_in_healthy_humans.png"><img alt="" src="https://upload.wikimedia.org/wikipedia/commons/thumb/3/34/EBV_infection_cycle_in_healthy_humans.png/350px-EBV_infection_cycle_in_healthy_humans.png" decoding="async" width="350" height="224" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/3/34/EBV_infection_cycle_in_healthy_humans.png/525px-EBV_infection_cycle_in_healthy_humans.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/34/EBV_infection_cycle_in_healthy_humans.png/700px-EBV_infection_cycle_in_healthy_humans.png 2x" data-file-width="3168" data-file-height="2028"></a></p><div><p>The EBV replication cycle</p></div></div></div>
<h4><span id="Entry_to_the_cell">Entry to the cell</span><span><span>[</span><a href="https://en.wikipedia.org/w/index.php?title=Epstein%E2%80%93Barr_virus&amp;action=edit&amp;section=6" title="Edit section: Entry to the cell">edit</a><span>]</span></span></h4>
<p>EBV can infect both B cells and epithelial cells. The mechanisms for entering these two cells are different.
</p><p>To enter B cells, viral <a href="https://en.wikipedia.org/wiki/Glycoprotein" title="Glycoprotein">glycoprotein</a> <a href="https://en.wikipedia.org/w/index.php?title=Gp350&amp;action=edit&amp;redlink=1" title="Gp350 (page does not exist)">gp350</a> binds to cellular receptor <a href="https://en.wikipedia.org/wiki/CD21" title="CD21">CD21</a> (also known as CR2).<sup id="cite_ref-entrez_1380_24-0"><a href="#cite_note-entrez_1380-24">[24]</a></sup> Then, viral glycoprotein gp42 interacts with cellular <a href="https://en.wikipedia.org/wiki/MHC_class_II" title="MHC class II">MHC class II</a> molecules. This triggers <a href="https://en.wikipedia.org/wiki/Lipid_bilayer_fusion" title="Lipid bilayer fusion">fusion</a> of the viral envelope with the cell membrane, allowing EBV to enter the B cell.<sup id="cite_ref-Progress_and_Problems_in_Understanding_21-2"><a href="#cite_note-Progress_and_Problems_in_Understanding-21">[21]</a></sup> Human CD35, also known as <a href="https://en.wikipedia.org/wiki/Complement_receptor_1" title="Complement receptor 1">complement receptor 1</a> (CR1), is an additional attachment factor for gp350/220, and can provide a route for entry of EBV into CD21-negative cells, including immature B-cells. EBV infection downregulates expression of CD35.<sup id="cite_ref-25"><a href="#cite_note-25">[25]</a></sup>
</p><p>To enter epithelial cells, viral protein BMRF-2  interacts with cellular β1 <a href="https://en.wikipedia.org/wiki/Integrins" title="Integrins">integrins</a>. Then, viral protein gH/gL interacts with cellular <a href="https://en.wikipedia.org/w/index.php?title=%CE%91v%CE%B26&amp;action=edit&amp;redlink=1" title="Αvβ6 (page does not exist)">αvβ6</a>/<a href="https://en.wikipedia.org/w/index.php?title=%CE%91v%CE%B28&amp;action=edit&amp;redlink=1" title="Αvβ8 (page does not exist)">αvβ8</a> integrins. This triggers <a href="https://en.wikipedia.org/wiki/Lipid_bilayer_fusion" title="Lipid bilayer fusion">fusion</a> of the viral envelope with the epithelial cell membrane, allowing EBV to enter the epithelial cell.<sup id="cite_ref-Progress_and_Problems_in_Understanding_21-3"><a href="#cite_note-Progress_and_Problems_in_Understanding-21">[21]</a></sup> Unlike B-cell entry, epithelial-cell entry is actually impeded by viral glycoprotein gp42.<sup id="cite_ref-entrez_1380_24-1"><a href="#cite_note-entrez_1380-24">[24]</a></sup>
</p><p>Once EBV enters the cell, the viral capsid dissolves and the viral genome is transported to the <a href="https://en.wikipedia.org/wiki/Cell_nucleus" title="Cell nucleus">cell nucleus</a>.
</p>
<h4><span id="Lytic_replication">Lytic replication</span><span><span>[</span><a href="https://en.wikipedia.org/w/index.php?title=Epstein%E2%80%93Barr_virus&amp;action=edit&amp;section=7" title="Edit section: Lytic replication">edit</a><span>]</span></span></h4>
<p>The <a href="https://en.wikipedia.org/wiki/Lytic_cycle" title="Lytic cycle">lytic cycle</a>, or productive infection, results in the production of infectious <a href="https://en.wikipedia.org/wiki/Virions" title="Virions">virions</a>. EBV can undergo lytic replication in both B cells and epithelial cells. In B cells, lytic replication normally only takes place after reactivation from <a href="#Latency">latency</a>. In epithelial cells, lytic replication often directly follows <a href="#Entry_to_the_cell">viral entry</a>.<sup id="cite_ref-Progress_and_Problems_in_Understanding_21-4"><a href="#cite_note-Progress_and_Problems_in_Understanding-21">[21]</a></sup>
</p><p>For lytic replication to occur, the viral genome must be linear. The latent EBV genome is circular, so it must linearize in the process of lytic reactivation. During lytic replication, viral <a href="https://en.wikipedia.org/wiki/DNA_polymerase" title="DNA polymerase">DNA polymerase</a> is responsible for copying the viral genome. This contrasts with latency, in which host-cell DNA polymerase copies the viral genome.<sup id="cite_ref-Progress_and_Problems_in_Understanding_21-5"><a href="#cite_note-Progress_and_Problems_in_Understanding-21">[21]</a></sup>
</p><p>Lytic gene products are produced in three consecutive stages: immediate-early, early, and late.<sup id="cite_ref-Progress_and_Problems_in_Understanding_21-6"><a href="#cite_note-Progress_and_Problems_in_Understanding-21">[21]</a></sup>
Immediate-early lytic gene products act as <a href="https://en.wikipedia.org/wiki/Transactivators" title="Transactivators">transactivators</a>, enhancing the <a href="https://en.wikipedia.org/wiki/Gene_expression" title="Gene expression">expression</a> of later lytic genes. Immediate-early lytic gene products include <a href="https://en.wikipedia.org/wiki/BZLF1" title="BZLF1">BZLF1</a> (also known as Zta, EB1, associated with its product gene <i>ZEBRA</i>) and <a href="https://en.wikipedia.org/w/index.php?title=BRLF1&amp;action=edit&amp;redlink=1" title="BRLF1 (page does not exist)">BRLF1</a> (associated with its product gene <i>Rta</i>).<sup id="cite_ref-Progress_and_Problems_in_Understanding_21-7"><a href="#cite_note-Progress_and_Problems_in_Understanding-21">[21]</a></sup>
Early lytic gene products have many more functions, such as replication, metabolism, and blockade of <a href="https://en.wikipedia.org/wiki/Antigen_processing" title="Antigen processing">antigen processing</a>. Early lytic gene products include <a href="https://en.wikipedia.org/w/index.php?title=BNLF2&amp;action=edit&amp;redlink=1" title="BNLF2 (page does not exist)">BNLF2</a>.<sup id="cite_ref-Progress_and_Problems_in_Understanding_21-8"><a href="#cite_note-Progress_and_Problems_in_Understanding-21">[21]</a></sup>
Finally, late lytic gene products tend to be proteins with structural roles, such as <a href="https://en.wikipedia.org/wiki/Epstein%E2%80%93Barr_virus_viral_capsid_antigen" title="Epstein–Barr virus viral capsid antigen">VCA</a>, which forms the viral <a href="https://en.wikipedia.org/wiki/Capsid" title="Capsid">capsid</a>. Other late lytic gene products, such as BCRF1, help EBV evade the immune system.<sup id="cite_ref-Progress_and_Problems_in_Understanding_21-9"><a href="#cite_note-Progress_and_Problems_in_Understanding-21">[21]</a></sup>
</p><p><a href="https://en.wikipedia.org/wiki/EGCG" title="EGCG">EGCG</a>, a polyphenol in <a href="https://en.wikipedia.org/wiki/Green_tea" title="Green tea">green tea</a>, has shown in a study to inhibit EBV spontaneous lytic infection at the DNA, gene transcription, and protein levels in a time- and <a href="https://en.wikipedia.org/wiki/Dose-dependent" title="Dose-dependent">dose-dependent</a> manner; the expression of EBV lytic genes<i> Zta, Rta</i>, and early antigen complex EA-D (induced by <i>Rta</i>), however, the highly stable <i><a href="https://en.wikipedia.org/wiki/EBNA-1" title="EBNA-1">EBNA-1</a></i> gene found across all stages of EBV infection is unaffected.<sup id="cite_ref-carcin_26-0"><a href="#cite_note-carcin-26">[26]</a></sup>   Specific inhibitors (to the pathways) suggest that <a href="https://en.wikipedia.org/wiki/MAPK/ERK_pathway" title="MAPK/ERK pathway">Ras/MEK/MAPK pathway</a> contributes to EBV lytic infection though BZLF1 and <a href="https://en.wikipedia.org/wiki/PI3-K" title="PI3-K">PI3-K</a> pathway through BRLF1, the latter completely abrogating the ability of a BRLF1 <a href="https://en.wikipedia.org/wiki/Adenoviridae#Use_in_treatment_of_unrelated_diseases" title="Adenoviridae">adenovirus vector</a> to induce the lytic form of EBV infection.<sup id="cite_ref-carcin_26-1"><a href="#cite_note-carcin-26">[26]</a></sup>  Additionally, the activation of some genes but not others is being studied to determine just how to induce immune destruction of latently infected B-cells by use of either <a href="https://en.wikipedia.org/wiki/12-O-Tetradecanoylphorbol-13-acetate" title="12-O-Tetradecanoylphorbol-13-acetate">TPA</a> or <a href="https://en.wikipedia.org/wiki/Sodium_butyrate" title="Sodium butyrate">sodium butyrate</a>.<sup id="cite_ref-carcin_26-2"><a href="#cite_note-carcin-26">[26]</a></sup>
</p>
<h4><span id="Latency">Latency</span><span><span>[</span><a href="https://en.wikipedia.org/w/index.php?title=Epstein%E2%80%93Barr_virus&amp;action=edit&amp;section=8" title="Edit section: Latency">edit</a><span>]</span></span></h4>
<p>Unlike lytic replication, <a href="https://en.wikipedia.org/wiki/Virus_latency" title="Virus latency">latency</a> does not result in production of virions.<sup id="cite_ref-Progress_and_Problems_in_Understanding_21-10"><a href="#cite_note-Progress_and_Problems_in_Understanding-21">[21]</a></sup>
Instead, the EBV genome circular DNA resides in the <a href="https://en.wikipedia.org/wiki/Cell_nucleus" title="Cell nucleus">cell nucleus</a> as an <a href="https://en.wikipedia.org/wiki/Episome" title="Episome">episome</a> and is copied by cellular <a href="https://en.wikipedia.org/wiki/DNA_polymerase" title="DNA polymerase">DNA polymerase</a>.<sup id="cite_ref-Progress_and_Problems_in_Understanding_21-11"><a href="#cite_note-Progress_and_Problems_in_Understanding-21">[21]</a></sup>
In latency, only a portion of EBV's genes are <a href="https://en.wikipedia.org/wiki/Gene_expression" title="Gene expression">expressed</a>.<sup id="cite_ref-Reactivation_of_Epstein-Barr_Virus_15-3"><a href="#cite_note-Reactivation_of_Epstein-Barr_Virus-15">[15]</a></sup><sup id="cite_ref-27"><a href="#cite_note-27">[27]</a></sup>
Latent EBV expresses its genes in one of three patterns, known as latency programs. EBV can latently persist within <a href="https://en.wikipedia.org/wiki/B_cells" title="B cells">B cells</a> and <a href="https://en.wikipedia.org/wiki/Epithelial_cells" title="Epithelial cells">epithelial cells</a>, but different latency programs are possible in the two types of cell.
</p><p>EBV can exhibit one of three latency programs: Latency I, Latency II, or Latency III. Each latency program leads to the production of a  limited, distinct set of viral <a href="https://en.wikipedia.org/wiki/Proteins" title="Proteins">proteins</a> and viral <a href="https://en.wikipedia.org/wiki/RNAs" title="RNAs">RNAs</a>.<sup id="cite_ref-pmid17446270_28-0"><a href="#cite_note-pmid17446270-28">[28]</a></sup><sup id="cite_ref-pmid19680535_29-0"><a href="#cite_note-pmid19680535-29">[29]</a></sup>
</p>
<table>

<tbody><tr>
<th>Gene Expressed</th>
<th><a href="https://en.wikipedia.org/wiki/EBNA-1" title="EBNA-1">EBNA-1</a></th>
<th><a href="https://en.wikipedia.org/wiki/EBNA-2" title="EBNA-2">EBNA-2</a></th>
<th><a href="https://en.wikipedia.org/wiki/EBNA-3" title="EBNA-3">EBNA-3</a>A</th>
<th><a href="https://en.wikipedia.org/wiki/EBNA-3" title="EBNA-3">EBNA-3</a>B</th>
<th><a href="https://en.wikipedia.org/wiki/EBNA-3" title="EBNA-3">EBNA-3</a>C</th>
<th>EBNA-LP</th>
<th><a href="https://en.wikipedia.org/wiki/LMP-1" title="LMP-1">LMP-1</a></th>
<th><a href="https://en.wikipedia.org/wiki/LMP-2" title="LMP-2">LMP-2</a>A</th>
<th><a href="https://en.wikipedia.org/wiki/LMP-2" title="LMP-2">LMP-2</a>B</th>
<th><a href="https://en.wikipedia.org/wiki/EBER" title="EBER">EBER</a>
</th></tr>
<tr>
<td>Product</td>
<td>Protein</td>
<td>Protein</td>
<td>Protein</td>
<td>Protein</td>
<td>Protein</td>
<td>Protein</td>
<td>Protein</td>
<td>Protein</td>
<td>Protein</td>
<td><a href="https://en.wikipedia.org/wiki/NcRNA" title="NcRNA">ncRNAs</a>
</td></tr>
<tr>
<td><b>Latency I</b></td>
<td>+</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>+
</td></tr>
<tr>
<td><b>Latency II</b></td>
<td>+</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>+</td>
<td>+</td>
<td>+</td>
<td>+</td>
<td>+
</td></tr>
<tr>
<td><b>Latency III</b></td>
<td>+</td>
<td>+</td>
<td>+</td>
<td>+</td>
<td>+</td>
<td>+</td>
<td>+</td>
<td>+</td>
<td>+</td>
<td>+
</td></tr></tbody></table>
<p>Also, a program is postulated in which all viral protein expression is shut off (Latency 0).
</p><p>Within B cells, all three latency programs are possible.<sup id="cite_ref-Reactivation_of_Epstein-Barr_Virus_15-4"><a href="#cite_note-Reactivation_of_Epstein-Barr_Virus-15">[15]</a></sup>
EBV latency within B cells usually progresses from Latency III to Latency II to Latency I. Each stage of latency uniquely influences B cell behavior.<sup id="cite_ref-Reactivation_of_Epstein-Barr_Virus_15-5"><a href="#cite_note-Reactivation_of_Epstein-Barr_Virus-15">[15]</a></sup>
Upon infecting a resting <a href="https://en.wikipedia.org/wiki/Naive_B_cell" title="Naive B cell">naive B cell</a>, EBV enters Latency III. The set of proteins and RNAs produced in Latency III transforms the B cell into a proliferating blast (also known as B cell activation).<sup id="cite_ref-Reactivation_of_Epstein-Barr_Virus_15-6"><a href="#cite_note-Reactivation_of_Epstein-Barr_Virus-15">[15]</a></sup><sup id="cite_ref-Progress_and_Problems_in_Understanding_21-12"><a href="#cite_note-Progress_and_Problems_in_Understanding-21">[21]</a></sup>
Later, the virus restricts its gene expression and enters Latency II. The more limited set of proteins and RNAs produced in Latency II induces the B cell to differentiate into a <a href="https://en.wikipedia.org/wiki/Memory_B_cell" title="Memory B cell">memory B cell</a>.<sup id="cite_ref-Reactivation_of_Epstein-Barr_Virus_15-7"><a href="#cite_note-Reactivation_of_Epstein-Barr_Virus-15">[15]</a></sup><sup id="cite_ref-Progress_and_Problems_in_Understanding_21-13"><a href="#cite_note-Progress_and_Problems_in_Understanding-21">[21]</a></sup>
Finally, EBV restricts gene expression even further and enters Latency I. Expression of EBNA-1 allows the EBV genome to replicate when the memory B cell divides.<sup id="cite_ref-Reactivation_of_Epstein-Barr_Virus_15-8"><a href="#cite_note-Reactivation_of_Epstein-Barr_Virus-15">[15]</a></sup><sup id="cite_ref-Progress_and_Problems_in_Understanding_21-14"><a href="#cite_note-Progress_and_Problems_in_Understanding-21">[21]</a></sup>
</p><p>Within epithelial cells, only Latency II is possible.<sup>[<i><a href="https://en.wikipedia.org/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (June 2012)">citation needed</span></a></i>]</sup>
</p><p>In primary infection, EBV replicates in oropharyngeal epithelial cells and establishes Latency III, II, and I infections in B-lymphocytes. EBV latent infection of B-lymphocytes is necessary for virus persistence, subsequent replication in epithelial cells, and release of infectious virus into saliva. EBV Latency III and II infections of B-lymphocytes, Latency II infection of oral epithelial cells, and Latency II infection of NK- or T-cell can result in malignancies, marked by uniform EBV genome presence and gene expression.<sup id="cite_ref-Robertsones_30-0"><a href="#cite_note-Robertsones-30">[30]</a></sup>
</p>
<h4><span id="Reactivation">Reactivation</span><span><span>[</span><a href="https://en.wikipedia.org/w/index.php?title=Epstein%E2%80%93Barr_virus&amp;action=edit&amp;section=9" title="Edit section: Reactivation">edit</a><span>]</span></span></h4>
<p>Latent EBV in B cells can be reactivated to switch to <a href="#Lytic_replication">lytic replication</a>. This is known to happen <i>in vivo</i>, but what triggers it is not known precisely. <i>In vitro</i>, latent EBV in B cells can be reactivated by stimulating the B cell receptor, so reactivation <i>in vivo</i> probably takes place when latently infected B cells respond to unrelated infections.<sup id="cite_ref-Progress_and_Problems_in_Understanding_21-15"><a href="#cite_note-Progress_and_Problems_in_Understanding-21">[21]</a></sup>
<i>In vitro</i>, latent EBV in B cells can also be reactivated by treating the cells with <a href="https://en.wikipedia.org/wiki/Sodium_butyrate" title="Sodium butyrate">sodium butyrate</a> or <a href="https://en.wikipedia.org/wiki/12-O-Tetradecanoylphorbol-13-acetate" title="12-O-Tetradecanoylphorbol-13-acetate">TPA</a>.<sup>[<i><a href="https://en.wikipedia.org/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (June 2012)">citation needed</span></a></i>]</sup>
</p>
<h3><span id="Transformation_of_B-lymphocytes">Transformation of B-lymphocytes</span><span><span>[</span><a href="https://en.wikipedia.org/w/index.php?title=Epstein%E2%80%93Barr_virus&amp;action=edit&amp;section=10" title="Edit section: Transformation of B-lymphocytes">edit</a><span>]</span></span></h3>
<p>When EBV infects B cells <i><a href="https://en.wikipedia.org/wiki/In_vitro" title="In vitro">in vitro</a></i>, <a href="https://en.wikipedia.org/wiki/Lymphoblastoid" title="Lymphoblastoid">lymphoblastoid</a> cell lines eventually emerge that are capable of indefinite growth. The growth transformation of these cell lines is the consequence of viral protein expression.
</p><p>EBNA-2, EBNA-3C, and LMP-1 are essential for transformation, whereas EBNA-LP and the EBERs are not.<sup id="cite_ref-Yates1985_31-0"><a href="#cite_note-Yates1985-31">[31]</a></sup>
</p><p>Following natural infection with EBV, the virus is thought to execute some or all of its repertoire of gene expression programs to establish a persistent infection. Given the initial absence of host <a href="https://en.wikipedia.org/wiki/Immunity_(medical)" title="Immunity (medical)">immunity</a>, the lytic cycle produces large numbers of virions to infect other (presumably) B-lymphocytes within the host.
</p><p>The latent programs reprogram and subvert infected B-lymphocytes to proliferate and bring infected cells to the sites at which the virus presumably persists. Eventually, when host immunity develops, the virus persists by turning off most (or possibly all) of its genes, only occasionally reactivating to produce fresh virions. A balance is eventually struck between occasional viral reactivation and host immune surveillance removing cells that activate viral gene expression.
</p><p>The site of persistence of EBV may be <a href="https://en.wikipedia.org/wiki/Bone_marrow" title="Bone marrow">bone marrow</a>. EBV-positive patients who have had their own bone marrow replaced with bone marrow from an EBV-negative donor are found to be EBV-negative after <a href="https://en.wikipedia.org/wiki/Organ_transplant" title="Organ transplant">transplantation</a>.<sup id="cite_ref-Gratama1988_32-0"><a href="#cite_note-Gratama1988-32">[32]</a></sup>
</p>
<h3><span id="Latent_antigens">Latent antigens</span><span><span>[</span><a href="https://en.wikipedia.org/w/index.php?title=Epstein%E2%80%93Barr_virus&amp;action=edit&amp;section=11" title="Edit section: Latent antigens">edit</a><span>]</span></span></h3>
<p>All EBV nuclear proteins are produced by alternative splicing of a transcript starting at either the Cp or Wp promoters at the left end of the <a href="https://en.wikipedia.org/wiki/Genome" title="Genome">genome</a> (in the conventional nomenclature). The genes are ordered <i>EBNA-LP/EBNA-2/EBNA-3A/EBNA-3B/EBNA-3C/EBNA-1</i> within the genome.
</p><p>The initiation <a href="https://en.wikipedia.org/wiki/Codon" title="Codon">codon</a> of the EBNA-LP coding region is created by an alternate splice of the nuclear protein transcript. In the absence of this initiation codon,<i> EBNA-2/EBNA-3A/EBNA-3B/EBNA-3C/EBNA-1</i> will be expressed depending on which of these genes is alternatively spliced into the transcript.
</p>
<h3><span id="Protein.2Fgenes"></span><span id="Protein/genes">Protein/genes</span><span><span>[</span><a href="https://en.wikipedia.org/w/index.php?title=Epstein%E2%80%93Barr_virus&amp;action=edit&amp;section=12" title="Edit section: Protein/genes">edit</a><span>]</span></span></h3>
<table>

<tbody><tr>
<th>Protein/gene/antigen
</th>
<th>Stage
</th>
<th>Description
</th></tr>
<tr>
<td><b><a href="https://en.wikipedia.org/wiki/Epstein%E2%80%93Barr_virus_nuclear_antigen_1" title="Epstein–Barr virus nuclear antigen 1">EBNA-1</a></b>
</td>
<td>latent+lytic
</td>
<td>EBNA-1 protein binds to a replication origin (oriP) within the viral genome and mediates replication and partitioning of the episome during division of the host cell. It is the only viral protein expressed during group I latency.
</td></tr>
<tr>
<td><b><a href="https://en.wikipedia.org/wiki/Epstein%E2%80%93Barr_virus_nuclear_antigen_2" title="Epstein–Barr virus nuclear antigen 2">EBNA-2</a></b>
</td>
<td>latent+lytic
</td>
<td>EBNA-2 is the main viral <a href="https://en.wikipedia.org/wiki/Transactivator" title="Transactivator">transactivator</a>.
</td></tr>
<tr>
<td><b><a href="https://en.wikipedia.org/wiki/Epstein%E2%80%93Barr_virus_nuclear_antigen_3" title="Epstein–Barr virus nuclear antigen 3">EBNA-3</a></b>
</td>
<td>latent+lytic
</td>
<td>These genes also bind the host <a href="https://en.wikipedia.org/wiki/RBPJ" title="RBPJ">RBP-Jκ</a> protein.
</td></tr>
<tr>
<td><b><a href="https://en.wikipedia.org/wiki/Epstein%E2%80%93Barr_virus_latent_membrane_protein_1" title="Epstein–Barr virus latent membrane protein 1">LMP-1</a></b>
</td>
<td>latent
</td>
<td>LMP-1 is a six-span <a href="https://en.wikipedia.org/wiki/Transmembrane" title="Transmembrane">transmembrane</a> protein that is also essential for EBV-mediated growth transformation.
</td></tr>
<tr>
<td><b><a href="https://en.wikipedia.org/wiki/Epstein%E2%80%93Barr_virus_latent_membrane_protein_2" title="Epstein–Barr virus latent membrane protein 2">LMP-2</a></b>
</td>
<td>latent
</td>
<td>LMP-2A/LMP-2B are transmembrane proteins that act to block <a href="https://en.wikipedia.org/wiki/Tyrosine_kinase" title="Tyrosine kinase">tyrosine kinase</a> signaling.
</td></tr>
<tr>
<td><b><a href="https://en.wikipedia.org/wiki/Epstein%E2%80%93Barr_virus-encoded_small_RNAs" title="Epstein–Barr virus-encoded small RNAs">EBER</a></b>
</td>
<td>latent
</td>
<td>EBER-1/EBER-2 are small nuclear RNAs, which bind to certain nucleoprotein particles, enabling binding to PKR (dsRNA-dependent serin/threonin protein kinase), thus inhibiting its function. EBERs are by far the most abundant EBV products transcribed in EBV infected cells. They are commonly used as targets for the detection of EBV in histological tissues.<sup id="cite_ref-33"><a href="#cite_note-33">[33]</a></sup> ER-particles also induce the production of IL-10, which enhances growth and inhibits cytotoxic T-cells.
</td></tr>

<tr>
<td><b><a href="https://en.wikipedia.org/wiki/Epstein%E2%80%93Barr_virus_small_nucleolar_RNA_1" title="Epstein–Barr virus small nucleolar RNA 1">v-snoRNA1</a></b>
</td>
<td>latent
</td>
<td><a href="https://en.wikipedia.org/wiki/Epstein%E2%80%93Barr_virus_small_nucleolar_RNA_1" title="Epstein–Barr virus small nucleolar RNA 1">Epstein–Barr virus snoRNA1</a> is a box CD-snoRNA generated by the virus during latency. V-snoRNA1 may act as a miRNA-like precursor that is processed into 24 nucleotide sized RNA fragments that target the 3'UTR of viral DNA polymerase mRNA.<sup id="cite_ref-pmid19680535_29-1"><a href="#cite_note-pmid19680535-29">[29]</a></sup>
</td></tr>

<tr>
<td><b><a href="https://en.wikipedia.org/wiki/Epstein%E2%80%93Barr_virus_stable_intronic-sequence_RNAs" title="Epstein–Barr virus stable intronic-sequence RNAs">ebv-sisRNA</a></b>
</td>
<td>latent
</td>
<td>Ebv-sisRNA-1 is a stable intronic sequence RNA generated during latency program III. After the <a href="https://en.wikipedia.org/wiki/EBER" title="EBER">EBERs</a>, it is the third-most abundant small RNA produced by the virus during this program.<sup id="cite_ref-Moss2013_34-0"><a href="#cite_note-Moss2013-34">[34]</a></sup>
</td></tr>
<tr>
<td><b>miRNAs</b>
</td>
<td>latent
</td>
<td>EBV microRNAs are encoded by two transcripts, one set in the <i>BART</i> gene and one set near the<i> BHRF1</i> cluster. The three <i>BHRF1</i> pri-miRNAS (generating four miRNAs) are expressed during type III latency, whereas the large cluster of <i>BART</i> miRNAs (up to 20 miRNAs) are expressed during type II latency. The functions of these miRNAs are currently unknown.
</td></tr>
<tr>
<td><a href="https://en.wikipedia.org/w/index.php?title=EBV-EA&amp;action=edit&amp;redlink=1" title="EBV-EA (page does not exist)">EBV-EA</a>
</td>
<td>lytic
</td>
<td>early antigen
</td></tr>
<tr>
<td><a href="https://en.wikipedia.org/w/index.php?title=EBV-MA&amp;action=edit&amp;redlink=1" title="EBV-MA (page does not exist)">EBV-MA</a>
</td>
<td>lytic
</td>
<td>membrane antigen
</td></tr>
<tr>
<td><a href="https://en.wikipedia.org/wiki/Epstein%E2%80%93Barr_virus_viral-capsid_antigen" title="Epstein–Barr virus viral-capsid antigen">EBV-VCA</a>
</td>
<td>lytic
</td>
<td>viral capsid antigen
</td></tr>
<tr>
<td>EBV-AN
</td>
<td>lytic
</td>
<td>alkaline nuclease<sup id="cite_ref-Buisson2009_35-0"><a href="#cite_note-Buisson2009-35">[35]</a></sup>
</td></tr></tbody></table>
<h3><span id="Subtypes_of_EBV">Subtypes of EBV</span><span><span>[</span><a href="https://en.wikipedia.org/w/index.php?title=Epstein%E2%80%93Barr_virus&amp;action=edit&amp;section=13" title="Edit section: Subtypes of EBV">edit</a><span>]</span></span></h3>
<p>EBV can be divided into two major types, EBV type 1 and EBV type 2. These two subtypes have different <a href="https://en.wikipedia.org/wiki/EBNA-3" title="EBNA-3">EBNA-3</a> genes. As a result, the two subtypes differ in their transforming capabilities and reactivation ability. Type 1 is dominant throughout most of the world, but the two types are equally prevalent in <a href="https://en.wikipedia.org/wiki/Africa" title="Africa">Africa</a>. One can distinguish EBV type 1 from EBV type 2 by cutting the viral genome with a <a href="https://en.wikipedia.org/wiki/Restriction_enzyme" title="Restriction enzyme">restriction enzyme</a> and comparing the resulting digestion patterns by <a href="https://en.wikipedia.org/wiki/Gel_electrophoresis" title="Gel electrophoresis">gel electrophoresis</a>.<sup id="cite_ref-Progress_and_Problems_in_Understanding_21-16"><a href="#cite_note-Progress_and_Problems_in_Understanding-21">[21]</a></sup>
</p>
<h2><span id="Role_in_disease">Role in disease</span><span><span>[</span><a href="https://en.wikipedia.org/w/index.php?title=Epstein%E2%80%93Barr_virus&amp;action=edit&amp;section=14" title="Edit section: Role in disease">edit</a><span>]</span></span></h2>
<p>EBV has been implicated in  several diseases, including <a href="https://en.wikipedia.org/wiki/Infectious_mononucleosis" title="Infectious mononucleosis">infectious mononucleosis</a>,<sup id="cite_ref-Benign_lymphadenopathy_36-0"><a href="#cite_note-Benign_lymphadenopathy-36">[36]</a></sup> <a href="https://en.wikipedia.org/wiki/Burkitt%27s_lymphoma" title="Burkitt's lymphoma">Burkitt's lymphoma</a>,<sup id="cite_ref-PannoneZamparese2014_37-0"><a href="#cite_note-PannoneZamparese2014-37">[37]</a></sup> <a href="https://en.wikipedia.org/wiki/Hodgkin%27s_lymphoma" title="Hodgkin's lymphoma">Hodgkin's lymphoma</a>,<sup id="cite_ref-38"><a href="#cite_note-38">[38]</a></sup> <a href="https://en.wikipedia.org/wiki/Stomach_cancer" title="Stomach cancer">stomach cancer</a>,<sup id="cite_ref-200000_cancers_13-1"><a href="#cite_note-200000_cancers-13">[13]</a></sup> <a href="https://en.wikipedia.org/wiki/Nasopharyngeal_carcinoma" title="Nasopharyngeal carcinoma">nasopharyngeal carcinoma</a>,<sup id="cite_ref-39"><a href="#cite_note-39">[39]</a></sup> <a href="https://en.wikipedia.org/wiki/Multiple_sclerosis" title="Multiple sclerosis">multiple sclerosis</a>,<sup id="cite_ref-pmid20369303_10-1"><a href="#cite_note-pmid20369303-10">[10]</a></sup><sup id="cite_ref-pmid25740864_40-0"><a href="#cite_note-pmid25740864-40">[40]</a></sup><sup id="cite_ref-Moreno_11-1"><a href="#cite_note-Moreno-11">[11]</a></sup> and <a href="https://en.wikipedia.org/wiki/Lymphomatoid_granulomatosis" title="Lymphomatoid granulomatosis">lymphomatoid granulomatosis</a>.<sup id="cite_ref-41"><a href="#cite_note-41">[41]</a></sup> Specifically, EBV infected B-cells have been shown to reside within the brain lesions of <a href="https://en.wikipedia.org/wiki/Multiple_sclerosis" title="Multiple sclerosis">multiple sclerosis</a> patients.<sup id="cite_ref-Moreno_11-2"><a href="#cite_note-Moreno-11">[11]</a></sup> Additional diseases that have been linked to EBV include <a href="https://en.wikipedia.org/wiki/Gianotti%E2%80%93Crosti_syndrome" title="Gianotti–Crosti syndrome">Gianotti–Crosti syndrome</a>, <a href="https://en.wikipedia.org/wiki/Erythema_multiforme" title="Erythema multiforme">erythema multiforme</a>, acute genital ulcers, <a href="https://en.wikipedia.org/wiki/Oral_hairy_leukoplakia" title="Oral hairy leukoplakia">oral hairy leukoplakia</a>.<sup id="cite_ref-42"><a href="#cite_note-42">[42]</a></sup> Hypersensitivity to mosquito bites has been associated with EBV infection.<sup id="cite_ref-pmid27900557_43-0"><a href="#cite_note-pmid27900557-43">[43]</a></sup>
</p><p>The Epstein–Barr virus has been implicated  in disorders related to <a href="https://en.wikipedia.org/wiki/Alpha-synuclein" title="Alpha-synuclein">alpha-synuclein</a> aggregation (e.g. <a href="https://en.wikipedia.org/wiki/Parkinson%27s_disease" title="Parkinson's disease">Parkinson's disease</a>, <a href="https://en.wikipedia.org/wiki/Dementia_with_Lewy_bodies" title="Dementia with Lewy bodies">dementia with Lewy bodies</a>, and <a href="https://en.wikipedia.org/wiki/Multiple_system_atrophy" title="Multiple system atrophy">multiple system atrophy</a>).<sup id="cite_ref-44"><a href="#cite_note-44">[44]</a></sup>
</p>
<h2><span id="History">History</span><span><span>[</span><a href="https://en.wikipedia.org/w/index.php?title=Epstein%E2%80%93Barr_virus&amp;action=edit&amp;section=15" title="Edit section: History">edit</a><span>]</span></span></h2>
<p>The Epstein–Barr virus was named after <a href="https://en.wikipedia.org/wiki/Michael_A._Epstein" title="Michael A. Epstein">Michael Anthony Epstein</a> (born 18 May 1921), now a professor emeritus at the <a href="https://en.wikipedia.org/wiki/University_of_Bristol" title="University of Bristol">University of Bristol</a>, and <a href="https://en.wikipedia.org/wiki/Yvonne_Barr" title="Yvonne Barr">Yvonne Barr</a> (1932–2016), a 1966 <a href="https://en.wikipedia.org/wiki/Ph.D" title="Ph.D">Ph.D</a> graduate from the <a href="https://en.wikipedia.org/wiki/University_of_London" title="University of London">University of London</a>, who together discovered<sup id="cite_ref-BBC_45-0"><a href="#cite_note-BBC-45">[45]</a></sup> and, in 1964, published on the existence of the virus.<sup id="cite_ref-46"><a href="#cite_note-46">[46]</a></sup> In 1961, Epstein, a <a href="https://en.wikipedia.org/wiki/Pathologist" title="Pathologist">pathologist</a> and expert <a href="https://en.wikipedia.org/wiki/Electron_microscope" title="Electron microscope">electron microscopist</a>, attended a lecture on "The Commonest Children's Cancer in Tropical Africa—A Hitherto Unrecognised Syndrome." This lecture, by <a href="https://en.wikipedia.org/wiki/Denis_Parsons_Burkitt" title="Denis Parsons Burkitt">Denis Parsons Burkitt</a>, a surgeon practicing in <a href="https://en.wikipedia.org/wiki/Uganda" title="Uganda">Uganda</a>, was the description of the "endemic variant" (pediatric form) of the disease that <a href="https://en.wikipedia.org/wiki/Burkitt%27s_lymphoma" title="Burkitt's lymphoma">bears his name</a>. In 1963, a specimen was sent from Uganda to <a href="https://en.wikipedia.org/wiki/Middlesex_Hospital" title="Middlesex Hospital">Middlesex Hospital</a> to be cultured. Virus particles were identified in the cultured cells, and the results were published in <i><a href="https://en.wikipedia.org/wiki/The_Lancet" title="The Lancet">The Lancet</a></i> in 1964 by Epstein, <a href="https://en.wikipedia.org/wiki/Bert_Achong" title="Bert Achong">Bert Achong</a>, and Barr. Cell lines were sent to <a href="https://en.wikipedia.org/wiki/Werner_and_Gertrude_Henle" title="Werner and Gertrude Henle">Werner and Gertrude Henle</a> at the <a href="https://en.wikipedia.org/wiki/Children%27s_Hospital_of_Philadelphia" title="Children's Hospital of Philadelphia">Children's Hospital of Philadelphia</a> who developed <a href="https://en.wikipedia.org/wiki/Serology" title="Serology">serological</a> markers. In 1967, a technician in their laboratory developed mononucleosis and they were able to compare a stored serum sample, showing that <a href="https://en.wikipedia.org/wiki/Antibody" title="Antibody">antibodies</a> to the virus developed.<sup id="cite_ref-47"><a href="#cite_note-47">[47]</a></sup><sup id="cite_ref-Robertson2005_48-0"><a href="#cite_note-Robertson2005-48">[48]</a></sup><sup id="cite_ref-49"><a href="#cite_note-49">[49]</a></sup> In 1968, they discovered that EBV can directly <a href="https://en.wikipedia.org/wiki/Immortalised_cell_line" title="Immortalised cell line">immortalize</a> B cells after infection, mimicking some forms of EBV-related infections,<sup id="cite_ref-pmid6261650_50-0"><a href="#cite_note-pmid6261650-50">[50]</a></sup> and confirmed the link between the virus and infectious mononucleosis.<sup id="cite_ref-isbn0-12-375147-0_51-0"><a href="#cite_note-isbn0-12-375147-0-51">[51]</a></sup>
</p>
<h2><span id="Research">Research</span><span><span>[</span><a href="https://en.wikipedia.org/w/index.php?title=Epstein%E2%80%93Barr_virus&amp;action=edit&amp;section=16" title="Edit section: Research">edit</a><span>]</span></span></h2>
<p>As a relatively complex virus, EBV is not yet fully understood. Laboratories around the world continue to study the virus and develop new ways to treat the diseases it causes. One popular way of studying EBV <i><a href="https://en.wikipedia.org/wiki/In_vitro" title="In vitro">in vitro</a></i> is to use <a href="https://en.wikipedia.org/wiki/Bacterial_artificial_chromosome" title="Bacterial artificial chromosome">bacterial artificial chromosomes</a>.<sup id="cite_ref-pmid18938248_52-0"><a href="#cite_note-pmid18938248-52">[52]</a></sup> Epstein–Barr virus can be maintained and manipulated in the laboratory in continual latency (a property shared with <a href="https://en.wikipedia.org/wiki/Kaposi%27s_sarcoma-associated_herpesvirus" title="Kaposi's sarcoma-associated herpesvirus">Kaposi's sarcoma-associated herpesvirus</a>, another of the eight human herpesviruses). Although many viruses are assumed to have this property during infection of their natural hosts, there is not an easily managed system for studying this part of the viral lifecycle.  Genomic studies of EBV have been able to explore lytic reactivation and regulation of the latent viral episome.<sup id="cite_ref-pmid22901543_53-0"><a href="#cite_note-pmid22901543-53">[53]</a></sup>
</p><p>Although under active research, an <a href="https://en.wikipedia.org/wiki/Epstein%E2%80%93Barr_virus_vaccine" title="Epstein–Barr virus vaccine">Epstein–Barr virus vaccine</a> is not yet available. The development of an effective vaccine could prevent up to 200,000 cancers globally per year.<sup id="cite_ref-200000_cancers_13-2"><a href="#cite_note-200000_cancers-13">[13]</a></sup> Like other <a href="https://en.wikipedia.org/wiki/Human_herpesvirus" title="Human herpesvirus">human herpesvirus</a>' Epstein-Barr might allow eradication via a course of the pro-drug <a href="https://en.wikipedia.org/wiki/Valaciclovir" title="Valaciclovir">Valaciclovir</a>, but further research is needed to determine if eradication is actually achievable.<sup id="cite_ref-54"><a href="#cite_note-54">[54]</a></sup>
</p>
<h2><span id="See_also">See also</span><span><span>[</span><a href="https://en.wikipedia.org/w/index.php?title=Epstein%E2%80%93Barr_virus&amp;action=edit&amp;section=17" title="Edit section: See also">edit</a><span>]</span></span></h2>

<ul><li><a href="https://en.wikipedia.org/wiki/Epstein%E2%80%93Barr_virus_infection" title="Epstein–Barr virus infection">Epstein–Barr virus infection</a></li>
<li><a href="https://en.wikipedia.org/wiki/James_Corson_Niederman" title="James Corson Niederman">James Corson Niederman</a>, the physician who proved how the Epstein–Barr virus is transmitted in infectious mononucleosis</li></ul>
<h2><span id="References">References</span><span><span>[</span><a href="https://en.wikipedia.org/w/index.php?title=Epstein%E2%80%93Barr_virus&amp;action=edit&amp;section=18" title="Edit section: References">edit</a><span>]</span></span></h2>
<div>
<ol>
<li id="cite_note-ICTV10-1"><span><b><a href="#cite_ref-ICTV10_1-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite><a rel="nofollow" href="https://talk.ictvonline.org/taxonomy/p/taxonomy-history?taxnode_id=20181486">"ICTV Taxonomy history: <i>Human gammaherpesvirus 4</i>"</a>. <i>International Committee on Taxonomy of Viruses (ICTV)</i><span>. Retrieved <span>10 January</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=International+Committee+on+Taxonomy+of+Viruses+%28ICTV%29&amp;rft.atitle=ICTV+Taxonomy+history%3A+Human+gammaherpesvirus+4&amp;rft_id=https%3A%2F%2Ftalk.ictvonline.org%2Ftaxonomy%2Fp%2Ftaxonomy-history%3Ftaxnode_id%3D20181486&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-pmid29885408-2"><span><b><a href="#cite_ref-pmid29885408_2-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Rezk SA, Zhao X, Weiss LM (September 2018). "Epstein-Barr virus (EBV)-associated lymphoid proliferations, a 2018 update". <i>Human Pathology</i>. <b>79</b>: 18–41. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1016%2Fj.humpath.2018.05.020">10.1016/j.humpath.2018.05.020</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/29885408">29885408</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Human+Pathology&amp;rft.atitle=Epstein-Barr+virus+%28EBV%29-associated+lymphoid+proliferations%2C+a+2018+update&amp;rft.volume=79&amp;rft.pages=18-41&amp;rft.date=2018-09&amp;rft_id=info%3Adoi%2F10.1016%2Fj.humpath.2018.05.020&amp;rft_id=info%3Apmid%2F29885408&amp;rft.aulast=Rezk&amp;rft.aufirst=SA&amp;rft.au=Zhao%2C+X&amp;rft.au=Weiss%2C+LM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-pmid19373526-3"><span><b><a href="#cite_ref-pmid19373526_3-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Maeda E, Akahane M, Kiryu S, Kato N, Yoshikawa T, Hayashi N,  et al. (January 2009). "Spectrum of Epstein-Barr virus-related diseases: a pictorial review". <i>Japanese Journal of Radiology</i>. <b>27</b> (1): 4–19. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1007%2Fs11604-008-0291-2">10.1007/s11604-008-0291-2</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/19373526">19373526</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Japanese+Journal+of+Radiology&amp;rft.atitle=Spectrum+of+Epstein-Barr+virus-related+diseases%3A+a+pictorial+review&amp;rft.volume=27&amp;rft.issue=1&amp;rft.pages=4-19&amp;rft.date=2009-01&amp;rft_id=info%3Adoi%2F10.1007%2Fs11604-008-0291-2&amp;rft_id=info%3Apmid%2F19373526&amp;rft.aulast=Maeda&amp;rft.aufirst=E&amp;rft.au=Akahane%2C+M&amp;rft.au=Kiryu%2C+S&amp;rft.au=Kato%2C+N&amp;rft.au=Yoshikawa%2C+T&amp;rft.au=Hayashi%2C+N&amp;rft.au=Aoki%2C+S&amp;rft.au=Minami%2C+M&amp;rft.au=Uozaki%2C+H&amp;rft.au=Fukayama%2C+M&amp;rft.au=Ohtomo%2C+K&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-Cherry-Peppers_2003-4"><span><b><a href="#cite_ref-Cherry-Peppers_2003_4-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Cherry-Peppers G, Daniels CO, Meeks V, Sanders CF, Reznik D (February 2003). <a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2568277">"Oral manifestations in the era of HAART"</a>. <i>Journal of the National Medical Association</i>. <b>95</b> (2 Suppl 2): 21S–32S. <a href="https://en.wikipedia.org/wiki/PubMed_Central" title="PubMed Central">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2568277">2568277</a></span>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/12656429">12656429</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+National+Medical+Association&amp;rft.atitle=Oral+manifestations+in+the+era+of+HAART&amp;rft.volume=95&amp;rft.issue=2+Suppl+2&amp;rft.pages=21S-32S&amp;rft.date=2003-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2568277&amp;rft_id=info%3Apmid%2F12656429&amp;rft.aulast=Cherry-Peppers&amp;rft.aufirst=G&amp;rft.au=Daniels%2C+CO&amp;rft.au=Meeks%2C+V&amp;rft.au=Sanders%2C+CF&amp;rft.au=Reznik%2C+D&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2568277&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-pmid28116304-5"><span><b><a href="#cite_ref-pmid28116304_5-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Mastria G, Mancini V, Viganò A, Di Piero V (2016). <a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223006">"Alice in Wonderland Syndrome: A Clinical and Pathophysiological Review"</a>. <i>BioMed Research International</i>. <b>2016</b>: 8243145. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1155%2F2016%2F8243145">10.1155/2016/8243145</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Central" title="PubMed Central">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223006">5223006</a></span>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/28116304">28116304</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BioMed+Research+International&amp;rft.atitle=Alice+in+Wonderland+Syndrome%3A+A+Clinical+and+Pathophysiological+Review&amp;rft.volume=2016&amp;rft.pages=8243145&amp;rft.date=2016&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5223006&amp;rft_id=info%3Apmid%2F28116304&amp;rft_id=info%3Adoi%2F10.1155%2F2016%2F8243145&amp;rft.aulast=Mastria&amp;rft.aufirst=G&amp;rft.au=Mancini%2C+V&amp;rft.au=Vigan%C3%B2%2C+A&amp;rft.au=Di+Piero%2C+V&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5223006&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-pmid14552515-6"><span><b><a href="#cite_ref-pmid14552515_6-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Nussinovitch M, Prais D, Volovitz B, Shapiro R, Amir J (September 2003). "Post-infectious acute cerebellar ataxia in children". <i>Clinical Pediatrics</i>. <b>42</b> (7): 581–4. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1177%2F000992280304200702">10.1177/000992280304200702</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/14552515">14552515</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Pediatrics&amp;rft.atitle=Post-infectious+acute+cerebellar+ataxia+in+children&amp;rft.volume=42&amp;rft.issue=7&amp;rft.pages=581-4&amp;rft.date=2003-09&amp;rft_id=info%3Adoi%2F10.1177%2F000992280304200702&amp;rft_id=info%3Apmid%2F14552515&amp;rft.aulast=Nussinovitch&amp;rft.aufirst=M&amp;rft.au=Prais%2C+D&amp;rft.au=Volovitz%2C+B&amp;rft.au=Shapiro%2C+R&amp;rft.au=Amir%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-pmid19028369-7"><span><b><a href="#cite_ref-pmid19028369_7-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Toussirot E, Roudier J (October 2008). "Epstein-Barr virus in autoimmune diseases". <i>Best Practice &amp; Research. Clinical Rheumatology</i>. <b>22</b> (5): 883–96. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1016%2Fj.berh.2008.09.007">10.1016/j.berh.2008.09.007</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/19028369">19028369</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Best+Practice+%26+Research.+Clinical+Rheumatology&amp;rft.atitle=Epstein-Barr+virus+in+autoimmune+diseases&amp;rft.volume=22&amp;rft.issue=5&amp;rft.pages=883-96&amp;rft.date=2008-10&amp;rft_id=info%3Adoi%2F10.1016%2Fj.berh.2008.09.007&amp;rft_id=info%3Apmid%2F19028369&amp;rft.aulast=Toussirot&amp;rft.aufirst=E&amp;rft.au=Roudier%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-pmid21871974-8"><span><b><a href="#cite_ref-pmid21871974_8-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Dreyfus DH (December 2011). "Autoimmune disease: A role for new anti-viral therapies?". <i>Autoimmunity Reviews</i>. <b>11</b> (2): 88–97. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1016%2Fj.autrev.2011.08.005">10.1016/j.autrev.2011.08.005</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/21871974">21871974</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Autoimmunity+Reviews&amp;rft.atitle=Autoimmune+disease%3A+A+role+for+new+anti-viral+therapies%3F&amp;rft.volume=11&amp;rft.issue=2&amp;rft.pages=88-97&amp;rft.date=2011-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.autrev.2011.08.005&amp;rft_id=info%3Apmid%2F21871974&amp;rft.aulast=Dreyfus&amp;rft.aufirst=DH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-pmid22312480-9"><span><b><a href="#cite_ref-pmid22312480_9-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Pender MP (2012). <a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270541">"CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis"</a>. <i>Autoimmune Diseases</i>. <b>2012</b>: 189096. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1155%2F2012%2F189096">10.1155/2012/189096</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Central" title="PubMed Central">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270541">3270541</a></span>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/22312480">22312480</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Autoimmune+Diseases&amp;rft.atitle=CD8%2B+T-Cell+Deficiency%2C+Epstein-Barr+Virus+Infection%2C+Vitamin+D+Deficiency%2C+and+Steps+to+Autoimmunity%3A+A+Unifying+Hypothesis&amp;rft.volume=2012&amp;rft.pages=189096&amp;rft.date=2012&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3270541&amp;rft_id=info%3Apmid%2F22312480&amp;rft_id=info%3Adoi%2F10.1155%2F2012%2F189096&amp;rft.aulast=Pender&amp;rft.aufirst=MP&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3270541&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-pmid20369303-10"><span>^ <a href="#cite_ref-pmid20369303_10-0"><span>Jump up to: </span><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid20369303_10-1"><sup><i><b>b</b></i></sup></a></span> <span><cite>Ascherio A, Munger KL (September 2010). "Epstein-barr virus infection and multiple sclerosis: a review". <i>Journal of Neuroimmune Pharmacology</i>. <b>5</b> (3): 271–7. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1007%2Fs11481-010-9201-3">10.1007/s11481-010-9201-3</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/20369303">20369303</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neuroimmune+Pharmacology&amp;rft.atitle=Epstein-barr+virus+infection+and+multiple+sclerosis%3A+a+review&amp;rft.volume=5&amp;rft.issue=3&amp;rft.pages=271-7&amp;rft.date=2010-09&amp;rft_id=info%3Adoi%2F10.1007%2Fs11481-010-9201-3&amp;rft_id=info%3Apmid%2F20369303&amp;rft.aulast=Ascherio&amp;rft.aufirst=A&amp;rft.au=Munger%2C+KL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-Moreno-11"><span>^ <a href="#cite_ref-Moreno_11-0"><span>Jump up to: </span><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Moreno_11-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Moreno_11-2"><sup><i><b>c</b></i></sup></a></span> <span><cite>Moreno MA, Or-Geva N, Aftab BT, Khanna R, Croze E, Steinman L, Han MH (July 2018). <a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994704">"Molecular signature of Epstein-Barr virus infection in MS brain lesions"</a>. <i>Neurology</i>. <b>5</b> (4): e466. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1212%2FNXI.0000000000000466">10.1212/NXI.0000000000000466</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Central" title="PubMed Central">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994704">5994704</a></span>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/29892607">29892607</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Molecular+signature+of+Epstein-Barr+virus+infection+in+MS+brain+lesions&amp;rft.volume=5&amp;rft.issue=4&amp;rft.pages=e466&amp;rft.date=2018-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5994704&amp;rft_id=info%3Apmid%2F29892607&amp;rft_id=info%3Adoi%2F10.1212%2FNXI.0000000000000466&amp;rft.aulast=Moreno&amp;rft.aufirst=MA&amp;rft.au=Or-Geva%2C+N&amp;rft.au=Aftab%2C+BT&amp;rft.au=Khanna%2C+R&amp;rft.au=Croze%2C+E&amp;rft.au=Steinman%2C+L&amp;rft.au=Han%2C+MH&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5994704&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-12"><span><b><a href="#cite_ref-12" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Hassani A, Corboy JR, Al-Salam S, Khan G (2018). <a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796799">"Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells"</a>. <i>PLOS ONE</i>. <b>13</b> (2): e0192109. <a href="https://en.wikipedia.org/wiki/Bibcode" title="Bibcode">Bibcode</a>:<a rel="nofollow" href="https://ui.adsabs.harvard.edu/abs/2018PLoSO..1392109H">2018PLoSO..1392109H</a>. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1371%2Fjournal.pone.0192109">10.1371/journal.pone.0192109</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Central" title="PubMed Central">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796799">5796799</a></span>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/29394264">29394264</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+ONE&amp;rft.atitle=Epstein-Barr+virus+is+present+in+the+brain+of+most+cases+of+multiple+sclerosis+and+may+engage+more+than+just+B+cells&amp;rft.volume=13&amp;rft.issue=2&amp;rft.pages=e0192109&amp;rft.date=2018&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5796799&amp;rft_id=info%3Apmid%2F29394264&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0192109&amp;rft_id=info%3Abibcode%2F2018PLoSO..1392109H&amp;rft.aulast=Hassani&amp;rft.aufirst=A&amp;rft.au=Corboy%2C+JR&amp;rft.au=Al-Salam%2C+S&amp;rft.au=Khan%2C+G&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5796799&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-200000_cancers-13"><span>^ <a href="#cite_ref-200000_cancers_13-0"><span>Jump up to: </span><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-200000_cancers_13-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-200000_cancers_13-2"><sup><i><b>c</b></i></sup></a></span> <span><cite><a rel="nofollow" href="http://www.cancerresearchuk.org/about-us/cancer-news/press-release/2014-03-24-developing-a-vaccine-for-the-epstein-barr-virus-could-prevent-up-to-200000-cancers-globally-say">"Developing a vaccine for the Epstein–Barr Virus could prevent up to 200,000 cancers globally say experts"</a>. 2014-03-24. <a rel="nofollow" href="https://web.archive.org/web/20170319073808/http://www.cancerresearchuk.org/about-us/cancer-news/press-release/2014-03-24-developing-a-vaccine-for-the-epstein-barr-virus-could-prevent-up-to-200000-cancers-globally-say">Archived</a> from the original on 2017-03-19.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Developing+a+vaccine+for+the+Epstein%E2%80%93Barr+Virus+could+prevent+up+to+200%2C000+cancers+globally+say+experts&amp;rft.date=2014-03-24&amp;rft_id=http%3A%2F%2Fwww.cancerresearchuk.org%2Fabout-us%2Fcancer-news%2Fpress-release%2F2014-03-24-developing-a-vaccine-for-the-epstein-barr-virus-could-prevent-up-to-200000-cancers-globally-say&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-14"><span><b><a href="#cite_ref-14" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Khan G, Hashim MJ (2014). <a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253616">"Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010"</a>. <i>Infectious Agents and Cancer</i>. <b>9</b> (1): 38. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1186%2F1750-9378-9-38">10.1186/1750-9378-9-38</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Central" title="PubMed Central">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253616">4253616</a></span>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/25473414">25473414</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Infectious+Agents+and+Cancer&amp;rft.atitle=Global+burden+of+deaths+from+Epstein-Barr+virus+attributable+malignancies+1990-2010&amp;rft.volume=9&amp;rft.issue=1&amp;rft.pages=38&amp;rft.date=2014&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4253616&amp;rft_id=info%3Apmid%2F25473414&amp;rft_id=info%3Adoi%2F10.1186%2F1750-9378-9-38&amp;rft.aulast=Khan&amp;rft.aufirst=G&amp;rft.au=Hashim%2C+MJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4253616&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-Reactivation_of_Epstein-Barr_Virus-15"><span>^ <a href="#cite_ref-Reactivation_of_Epstein-Barr_Virus_15-0"><span>Jump up to: </span><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Reactivation_of_Epstein-Barr_Virus_15-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Reactivation_of_Epstein-Barr_Virus_15-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Reactivation_of_Epstein-Barr_Virus_15-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Reactivation_of_Epstein-Barr_Virus_15-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Reactivation_of_Epstein-Barr_Virus_15-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Reactivation_of_Epstein-Barr_Virus_15-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Reactivation_of_Epstein-Barr_Virus_15-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Reactivation_of_Epstein-Barr_Virus_15-8"><sup><i><b>i</b></i></sup></a></span> <span><cite>Amon W, Farrell PJ (November 2004). "Reactivation of Epstein-Barr virus from latency". <i>Reviews in Medical Virology</i>. <b>15</b> (3): 149–56. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1002%2Frmv.456">10.1002/rmv.456</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/15546128">15546128</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reviews+in+Medical+Virology&amp;rft.atitle=Reactivation+of+Epstein-Barr+virus+from+latency&amp;rft.volume=15&amp;rft.issue=3&amp;rft.pages=149-56&amp;rft.date=2004-11&amp;rft_id=info%3Adoi%2F10.1002%2Frmv.456&amp;rft_id=info%3Apmid%2F15546128&amp;rft.aulast=Amon&amp;rft.aufirst=W&amp;rft.au=Farrell%2C+PJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-CDC_–_Epstein–Barr_Virus_and_Infectious_Mononucleosis-16"><span><b><a href="#cite_ref-CDC_–_Epstein–Barr_Virus_and_Infectious_Mononucleosis_16-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><a rel="nofollow" href="https://www.cdc.gov/epstein-barr/about-ebv.html">About 90% of adults have antibodies that show that they have a current or past EBV infection.</a> <a rel="nofollow" href="https://web.archive.org/web/20160808045418/http://www.cdc.gov/epstein-barr/about-ebv.html">Archived</a> 2016-08-08 at the <a href="https://en.wikipedia.org/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a> National Center for Infectious Diseases</span>
</li>
<li id="cite_note-17"><span><b><a href="#cite_ref-17" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>ACP. <a rel="nofollow" href="http://annals.org/aim/fullarticle/668505/epstein-barr-virus-infections-biology-pathogenesis-management">"Epstein–Barr Virus Infections: Biology, Pathogenesis, and Management"</a>. ACP. <a rel="nofollow" href="https://web.archive.org/web/20171208231554/http://annals.org/aim/fullarticle/668505/epstein-barr-virus-infections-biology-pathogenesis-management">Archived</a> from the original on 2017-12-08<span>. Retrieved <span>2017-12-08</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Epstein%E2%80%93Barr+Virus+Infections%3A+Biology%2C+Pathogenesis%2C+and+Management.&amp;rft.pub=ACP&amp;rft.au=ACP&amp;rft_id=http%3A%2F%2Fannals.org%2Faim%2Ffullarticle%2F668505%2Fepstein-barr-virus-infections-biology-pathogenesis-management&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-18"><span><b><a href="#cite_ref-18" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>CDC. <a rel="nofollow" href="https://web.archive.org/web/20120420113839/http://www.cdc.gov/ncidod/diseases/ebv.htm">"Epstein–Barr Virus and Infectious Mononucleosis"</a>. CDC. Archived from <a rel="nofollow" href="https://www.cdc.gov/ncidod/diseases/ebv.htm">the original</a> on 2012-04-20<span>. Retrieved <span>2011-12-29</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Epstein%E2%80%93Barr+Virus+and+Infectious+Mononucleosis&amp;rft.pub=CDC&amp;rft.au=CDC&amp;rft_id=https%3A%2F%2Fwww.cdc.gov%2Fncidod%2Fdiseases%2Febv.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-19"><span><b><a href="#cite_ref-19" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Khan G, Miyashita EM, Yang B, Babcock GJ, Thorley-Lawson DA (August 1996). "Is EBV persistence in vivo a model for B cell homeostasis?". <i>Immunity</i>. <b>5</b> (2): 173–9. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1016%2Fs1074-7613%2800%2980493-8">10.1016/s1074-7613(00)80493-8</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/8769480">8769480</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Immunity&amp;rft.atitle=Is+EBV+persistence+in+vivo+a+model+for+B+cell+homeostasis%3F&amp;rft.volume=5&amp;rft.issue=2&amp;rft.pages=173-9&amp;rft.date=1996-08&amp;rft_id=info%3Adoi%2F10.1016%2Fs1074-7613%2800%2980493-8&amp;rft_id=info%3Apmid%2F8769480&amp;rft.aulast=Khan&amp;rft.aufirst=G&amp;rft.au=Miyashita%2C+EM&amp;rft.au=Yang%2C+B&amp;rft.au=Babcock%2C+GJ&amp;rft.au=Thorley-Lawson%2C+DA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-20"><span><b><a href="#cite_ref-20" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.cdc.gov/epstein-barr/about-ebv.html">"About Epstein–Barr Virus (EBV)"</a>. Centers for Disease Control and Prevention. 14 September 2016.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=About+Epstein%E2%80%93Barr+Virus+%28EBV%29&amp;rft.pub=Centers+for+Disease+Control+and+Prevention&amp;rft.date=2016-09-14&amp;rft_id=https%3A%2F%2Fwww.cdc.gov%2Fepstein-barr%2Fabout-ebv.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-Progress_and_Problems_in_Understanding-21"><span>^ <a href="#cite_ref-Progress_and_Problems_in_Understanding_21-0"><span>Jump up to: </span><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Progress_and_Problems_in_Understanding_21-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Progress_and_Problems_in_Understanding_21-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Progress_and_Problems_in_Understanding_21-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Progress_and_Problems_in_Understanding_21-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Progress_and_Problems_in_Understanding_21-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Progress_and_Problems_in_Understanding_21-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Progress_and_Problems_in_Understanding_21-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Progress_and_Problems_in_Understanding_21-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Progress_and_Problems_in_Understanding_21-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Progress_and_Problems_in_Understanding_21-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Progress_and_Problems_in_Understanding_21-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Progress_and_Problems_in_Understanding_21-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Progress_and_Problems_in_Understanding_21-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Progress_and_Problems_in_Understanding_21-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-Progress_and_Problems_in_Understanding_21-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-Progress_and_Problems_in_Understanding_21-16"><sup><i><b>q</b></i></sup></a></span> <span><cite>Odumade OA, Hogquist KA, Balfour HH (January 2011). <a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021204">"Progress and problems in understanding and managing primary Epstein-Barr virus infections"</a>. <i>Clinical Microbiology Reviews</i>. <b>24</b> (1): 193–209. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1128%2FCMR.00044-10">10.1128/CMR.00044-10</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Central" title="PubMed Central">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021204">3021204</a></span>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/21233512">21233512</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Microbiology+Reviews&amp;rft.atitle=Progress+and+problems+in+understanding+and+managing+primary+Epstein-Barr+virus+infections&amp;rft.volume=24&amp;rft.issue=1&amp;rft.pages=193-209&amp;rft.date=2011-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3021204&amp;rft_id=info%3Apmid%2F21233512&amp;rft_id=info%3Adoi%2F10.1128%2FCMR.00044-10&amp;rft.aulast=Odumade&amp;rft.aufirst=OA&amp;rft.au=Hogquist%2C+KA&amp;rft.au=Balfour%2C+HH&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3021204&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-22"><span><b><a href="#cite_ref-22" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Shannon-Lowe C, Rowe M (February 2014). "Epstein Barr virus entry; kissing and conjugation". <i>Current Opinion in Virology</i>. <b>4</b>: 78–84. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1016%2Fj.coviro.2013.12.001">10.1016/j.coviro.2013.12.001</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/24553068">24553068</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Virology&amp;rft.atitle=Epstein+Barr+virus+entry%3B+kissing+and+conjugation&amp;rft.volume=4&amp;rft.pages=78-84&amp;rft.date=2014-02&amp;rft_id=info%3Adoi%2F10.1016%2Fj.coviro.2013.12.001&amp;rft_id=info%3Apmid%2F24553068&amp;rft.aulast=Shannon-Lowe&amp;rft.aufirst=C&amp;rft.au=Rowe%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-23"><span><b><a href="#cite_ref-23" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Wang X, Hutt-Fletcher LM (January 1998). <a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC109360">"Epstein-Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect"</a>. <i>Journal of Virology</i>. <b>72</b> (1): 158–63. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1128%2Fjvi.72.1.158-163.1998">10.1128/jvi.72.1.158-163.1998</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Central" title="PubMed Central">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC109360">109360</a></span>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/9420211">9420211</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Virology&amp;rft.atitle=Epstein-Barr+virus+lacking+glycoprotein+gp42+can+bind+to+B+cells+but+is+not+able+to+infect&amp;rft.volume=72&amp;rft.issue=1&amp;rft.pages=158-63&amp;rft.date=1998-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC109360&amp;rft_id=info%3Apmid%2F9420211&amp;rft_id=info%3Adoi%2F10.1128%2Fjvi.72.1.158-163.1998&amp;rft.aulast=Wang&amp;rft.aufirst=X&amp;rft.au=Hutt-Fletcher%2C+LM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC109360&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-entrez_1380-24"><span>^ <a href="#cite_ref-entrez_1380_24-0"><span>Jump up to: </span><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-entrez_1380_24-1"><sup><i><b>b</b></i></sup></a></span> <span><cite><a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&amp;Cmd=ShowDetailView&amp;TermToSearch=1380">"Entrez Gene: CR2 complement component (3d/Epstein Barr virus) receptor 2"</a>. <a rel="nofollow" href="https://web.archive.org/web/20101205081110/http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene">Archived</a> from the original on 2010-12-05.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Entrez+Gene%3A+CR2+complement+component+%283d%2FEpstein+Barr+virus%29+receptor+2&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fsites%2Fentrez%3FDb%3Dgene%26Cmd%3DShowDetailView%26TermToSearch%3D1380&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-25"><span><b><a href="#cite_ref-25" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Ogembo JG, Kannan L, Ghiran I, Nicholson-Weller A, Finberg RW, Tsokos GC, Fingeroth JD (February 2013). <a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3633082">"Human complement receptor type 1/CD35 is an Epstein-Barr Virus receptor"</a>. <i>Cell Reports</i>. <b>3</b> (2): 371–85. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1016%2Fj.celrep.2013.01.023">10.1016/j.celrep.2013.01.023</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Central" title="PubMed Central">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3633082">3633082</a></span>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/23416052">23416052</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell+Reports&amp;rft.atitle=Human+complement+receptor+type+1%2FCD35+is+an+Epstein-Barr+Virus+receptor&amp;rft.volume=3&amp;rft.issue=2&amp;rft.pages=371-85&amp;rft.date=2013-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3633082&amp;rft_id=info%3Apmid%2F23416052&amp;rft_id=info%3Adoi%2F10.1016%2Fj.celrep.2013.01.023&amp;rft.aulast=Ogembo&amp;rft.aufirst=JG&amp;rft.au=Kannan%2C+L&amp;rft.au=Ghiran%2C+I&amp;rft.au=Nicholson-Weller%2C+A&amp;rft.au=Finberg%2C+RW&amp;rft.au=Tsokos%2C+GC&amp;rft.au=Fingeroth%2C+JD&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3633082&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-carcin-26"><span>^ <a href="#cite_ref-carcin_26-0"><span>Jump up to: </span><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-carcin_26-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-carcin_26-2"><sup><i><b>c</b></i></sup></a></span> <span><cite>Liu S, Li H, Chen L, Yang L, Li L, Tao Y,  et al. (March 2013). "(-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves ERK1/2 and PI3-K/Akt signaling in EBV-positive cells". <i>Carcinogenesis</i>. <b>34</b> (3): 627–37. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1093%2Fcarcin%2Fbgs364">10.1093/carcin/bgs364</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/23180656">23180656</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Carcinogenesis&amp;rft.atitle=%28-%29-Epigallocatechin-3-gallate+inhibition+of+Epstein-Barr+virus+spontaneous+lytic+infection+involves+ERK1%2F2+and+PI3-K%2FAkt+signaling+in+EBV-positive+cells&amp;rft.volume=34&amp;rft.issue=3&amp;rft.pages=627-37&amp;rft.date=2013-03&amp;rft_id=info%3Adoi%2F10.1093%2Fcarcin%2Fbgs364&amp;rft_id=info%3Apmid%2F23180656&amp;rft.aulast=Liu&amp;rft.aufirst=S&amp;rft.au=Li%2C+H&amp;rft.au=Chen%2C+L&amp;rft.au=Yang%2C+L&amp;rft.au=Li%2C+L&amp;rft.au=Tao%2C+Y&amp;rft.au=Li%2C+W&amp;rft.au=Li%2C+Z&amp;rft.au=Liu%2C+H&amp;rft.au=Tang%2C+M&amp;rft.au=Bode%2C+AM&amp;rft.au=Dong%2C+Z&amp;rft.au=Cao%2C+Y&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-27"><span><b><a href="#cite_ref-27" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Thorley-Lawson DA, Miyashita EM, Khan G (May 1996). "Epstein-Barr virus and the B cell: that's all it takes". <i>Trends in Microbiology</i>. <b>4</b> (5): 204–8. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1016%2Fs0966-842x%2896%2990020-7">10.1016/s0966-842x(96)90020-7</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/8727601">8727601</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Trends+in+Microbiology&amp;rft.atitle=Epstein-Barr+virus+and+the+B+cell%3A+that%27s+all+it+takes&amp;rft.volume=4&amp;rft.issue=5&amp;rft.pages=204-8&amp;rft.date=1996-05&amp;rft_id=info%3Adoi%2F10.1016%2Fs0966-842x%2896%2990020-7&amp;rft_id=info%3Apmid%2F8727601&amp;rft.aulast=Thorley-Lawson&amp;rft.aufirst=DA&amp;rft.au=Miyashita%2C+EM&amp;rft.au=Khan%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-pmid17446270-28"><span><b><a href="#cite_ref-pmid17446270_28-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Calderwood MA, Venkatesan K, Xing L, Chase MR, Vazquez A, Holthaus AM,  et al. (May 2007). <a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1863443">"Epstein-Barr virus and virus human protein interaction maps"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>104</b> (18): 7606–11. <a href="https://en.wikipedia.org/wiki/Bibcode" title="Bibcode">Bibcode</a>:<a rel="nofollow" href="https://ui.adsabs.harvard.edu/abs/2007PNAS..104.7606C">2007PNAS..104.7606C</a>. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1073%2Fpnas.0702332104">10.1073/pnas.0702332104</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Central" title="PubMed Central">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1863443">1863443</a></span>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/17446270">17446270</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&amp;rft.atitle=Epstein-Barr+virus+and+virus+human+protein+interaction+maps&amp;rft.volume=104&amp;rft.issue=18&amp;rft.pages=7606-11&amp;rft.date=2007-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1863443&amp;rft_id=info%3Apmid%2F17446270&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.0702332104&amp;rft_id=info%3Abibcode%2F2007PNAS..104.7606C&amp;rft.aulast=Calderwood&amp;rft.aufirst=MA&amp;rft.au=Venkatesan%2C+K&amp;rft.au=Xing%2C+L&amp;rft.au=Chase%2C+MR&amp;rft.au=Vazquez%2C+A&amp;rft.au=Holthaus%2C+AM&amp;rft.au=Ewence%2C+AE&amp;rft.au=Li%2C+N&amp;rft.au=Hirozane-Kishikawa%2C+T&amp;rft.au=Hill%2C+DE&amp;rft.au=Vidal%2C+M&amp;rft.au=Kieff%2C+E&amp;rft.au=Johannsen%2C+E&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1863443&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span> The nomenclature used here is that of Kieff. Other laboratories use different nomenclatures.</span>
</li>
<li id="cite_note-pmid19680535-29"><span>^ <a href="#cite_ref-pmid19680535_29-0"><span>Jump up to: </span><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid19680535_29-1"><sup><i><b>b</b></i></sup></a></span> <span><cite>Hutzinger R, Feederle R, Mrazek J, Schiefermeier N, Balwierz PJ, Zavolan M,  et al. (August 2009). <a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2718842">"Expression and processing of a small nucleolar RNA from the Epstein-Barr virus genome"</a>. <i>PLoS Pathogens</i>. <b>5</b> (8): e1000547. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1371%2Fjournal.ppat.1000547">10.1371/journal.ppat.1000547</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Central" title="PubMed Central">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2718842">2718842</a></span>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/19680535">19680535</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLoS+Pathogens&amp;rft.atitle=Expression+and+processing+of+a+small+nucleolar+RNA+from+the+Epstein-Barr+virus+genome&amp;rft.volume=5&amp;rft.issue=8&amp;rft.pages=e1000547&amp;rft.date=2009-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2718842&amp;rft_id=info%3Apmid%2F19680535&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.ppat.1000547&amp;rft.aulast=Hutzinger&amp;rft.aufirst=R&amp;rft.au=Feederle%2C+R&amp;rft.au=Mrazek%2C+J&amp;rft.au=Schiefermeier%2C+N&amp;rft.au=Balwierz%2C+PJ&amp;rft.au=Zavolan%2C+M&amp;rft.au=Polacek%2C+N&amp;rft.au=Delecluse%2C+HJ&amp;rft.au=H%C3%BCttenhofer%2C+A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2718842&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-Robertsones-30"><span><b><a href="#cite_ref-Robertsones_30-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Robertson ES, ed. (2010). <i>Epstein–Barr Virus: Latency and Transformation</i>. <a href="https://en.wikipedia.org/wiki/Caister_Academic_Press" title="Caister Academic Press">Caister Academic Press</a>. <a href="https://en.wikipedia.org/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&nbsp;<a href="https://en.wikipedia.org/wiki/Special:BookSources/978-1-904455-62-2" title="Special:BookSources/978-1-904455-62-2"><bdi>978-1-904455-62-2</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Epstein%E2%80%93Barr+Virus%3A+Latency+and+Transformation&amp;rft.pub=Caister+Academic+Press&amp;rft.date=2010&amp;rft.isbn=978-1-904455-62-2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-Yates1985-31"><span><b><a href="#cite_ref-Yates1985_31-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Yates JL, Warren N, Sugden B (1985). "Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells". <i>Nature</i>. <b>313</b> (6005): 812–5. <a href="https://en.wikipedia.org/wiki/Bibcode" title="Bibcode">Bibcode</a>:<a rel="nofollow" href="https://ui.adsabs.harvard.edu/abs/1985Natur.313..812Y">1985Natur.313..812Y</a>. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1038%2F313812a0">10.1038/313812a0</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/2983224">2983224</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Stable+replication+of+plasmids+derived+from+Epstein-Barr+virus+in+various+mammalian+cells&amp;rft.volume=313&amp;rft.issue=6005&amp;rft.pages=812-5&amp;rft.date=1985&amp;rft_id=info%3Apmid%2F2983224&amp;rft_id=info%3Adoi%2F10.1038%2F313812a0&amp;rft_id=info%3Abibcode%2F1985Natur.313..812Y&amp;rft.aulast=Yates&amp;rft.aufirst=JL&amp;rft.au=Warren%2C+N&amp;rft.au=Sugden%2C+B&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-Gratama1988-32"><span><b><a href="#cite_ref-Gratama1988_32-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Gratama JW, Oosterveer MA, Zwaan FE, Lepoutre J, Klein G, Ernberg I (November 1988). <a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC282526">"Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>85</b> (22): 8693–6. <a href="https://en.wikipedia.org/wiki/Bibcode" title="Bibcode">Bibcode</a>:<a rel="nofollow" href="https://ui.adsabs.harvard.edu/abs/1988PNAS...85.8693G">1988PNAS...85.8693G</a>. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1073%2Fpnas.85.22.8693">10.1073/pnas.85.22.8693</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Central" title="PubMed Central">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC282526">282526</a></span>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/2847171">2847171</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&amp;rft.atitle=Eradication+of+Epstein-Barr+virus+by+allogeneic+bone+marrow+transplantation%3A+implications+for+sites+of+viral+latency&amp;rft.volume=85&amp;rft.issue=22&amp;rft.pages=8693-6&amp;rft.date=1988-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC282526&amp;rft_id=info%3Apmid%2F2847171&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.85.22.8693&amp;rft_id=info%3Abibcode%2F1988PNAS...85.8693G&amp;rft.aulast=Gratama&amp;rft.aufirst=JW&amp;rft.au=Oosterveer%2C+MA&amp;rft.au=Zwaan%2C+FE&amp;rft.au=Lepoutre%2C+J&amp;rft.au=Klein%2C+G&amp;rft.au=Ernberg%2C+I&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC282526&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-33"><span><b><a href="#cite_ref-33" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Khan G, Coates PJ, Kangro HO, Slavin G (July 1992). <a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC495191">"Epstein Barr virus (EBV) encoded small RNAs: targets for detection by in situ hybridisation with oligonucleotide probes"</a>. <i>Journal of Clinical Pathology</i>. <b>45</b> (7): 616–20. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1136%2Fjcp.45.7.616">10.1136/jcp.45.7.616</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Central" title="PubMed Central">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC495191">495191</a></span>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/1325480">1325480</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Pathology&amp;rft.atitle=Epstein+Barr+virus+%28EBV%29+encoded+small+RNAs%3A+targets+for+detection+by+in+situ+hybridisation+with+oligonucleotide+probes&amp;rft.volume=45&amp;rft.issue=7&amp;rft.pages=616-20&amp;rft.date=1992-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC495191&amp;rft_id=info%3Apmid%2F1325480&amp;rft_id=info%3Adoi%2F10.1136%2Fjcp.45.7.616&amp;rft.aulast=Khan&amp;rft.aufirst=G&amp;rft.au=Coates%2C+PJ&amp;rft.au=Kangro%2C+HO&amp;rft.au=Slavin%2C+G&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC495191&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-Moss2013-34"><span><b><a href="#cite_ref-Moss2013_34-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Moss WN, Steitz JA (August 2013). <a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751371">"Genome-wide analyses of Epstein-Barr virus reveal conserved RNA structures and a novel stable intronic sequence RNA"</a>. <i>BMC Genomics</i>. <b>14</b>: 543. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1186%2F1471-2164-14-543">10.1186/1471-2164-14-543</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Central" title="PubMed Central">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751371">3751371</a></span>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/23937650">23937650</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMC+Genomics&amp;rft.atitle=Genome-wide+analyses+of+Epstein-Barr+virus+reveal+conserved+RNA+structures+and+a+novel+stable+intronic+sequence+RNA&amp;rft.volume=14&amp;rft.pages=543&amp;rft.date=2013-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3751371&amp;rft_id=info%3Apmid%2F23937650&amp;rft_id=info%3Adoi%2F10.1186%2F1471-2164-14-543&amp;rft.aulast=Moss&amp;rft.aufirst=WN&amp;rft.au=Steitz%2C+JA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3751371&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-Buisson2009-35"><span><b><a href="#cite_ref-Buisson2009_35-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Buisson M, Géoui T, Flot D, Tarbouriech N, Ressing ME, Wiertz EJ, Burmeister WP (August 2009). "A bridge crosses the active-site canyon of the Epstein-Barr virus nuclease with DNase and RNase activities". <i>Journal of Molecular Biology</i>. <b>391</b> (4): 717–28. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1016%2Fj.jmb.2009.06.034">10.1016/j.jmb.2009.06.034</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/19538972">19538972</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Molecular+Biology&amp;rft.atitle=A+bridge+crosses+the+active-site+canyon+of+the+Epstein-Barr+virus+nuclease+with+DNase+and+RNase+activities&amp;rft.volume=391&amp;rft.issue=4&amp;rft.pages=717-28&amp;rft.date=2009-08&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jmb.2009.06.034&amp;rft_id=info%3Apmid%2F19538972&amp;rft.aulast=Buisson&amp;rft.aufirst=M&amp;rft.au=G%C3%A9oui%2C+T&amp;rft.au=Flot%2C+D&amp;rft.au=Tarbouriech%2C+N&amp;rft.au=Ressing%2C+ME&amp;rft.au=Wiertz%2C+EJ&amp;rft.au=Burmeister%2C+WP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-Benign_lymphadenopathy-36"><span><b><a href="#cite_ref-Benign_lymphadenopathy_36-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Weiss LM, O'Malley D (January 2013). "Benign lymphadenopathies". <i>Modern Pathology</i>. 26 Suppl 1 (Supplement 1): S88-96. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1038%2Fmodpathol.2012.176">10.1038/modpathol.2012.176</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/23281438">23281438</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Modern+Pathology&amp;rft.atitle=Benign+lymphadenopathies&amp;rft.volume=26+Suppl+1&amp;rft.issue=Supplement+1&amp;rft.pages=S88-96&amp;rft.date=2013-01&amp;rft_id=info%3Adoi%2F10.1038%2Fmodpathol.2012.176&amp;rft_id=info%3Apmid%2F23281438&amp;rft.aulast=Weiss&amp;rft.aufirst=LM&amp;rft.au=O%27Malley%2C+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-PannoneZamparese2014-37"><span><b><a href="#cite_ref-PannoneZamparese2014_37-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Pannone G, Zamparese R, Pace M, Pedicillo MC, Cagiano S, Somma P,  et al. (2014). <a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216353">"The role of EBV in the pathogenesis of Burkitt's Lymphoma: an Italian hospital based survey"</a>. <i>Infectious Agents and Cancer</i>. <b>9</b> (1): 34. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1186%2F1750-9378-9-34">10.1186/1750-9378-9-34</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Central" title="PubMed Central">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216353">4216353</a></span>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/25364378">25364378</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Infectious+Agents+and+Cancer&amp;rft.atitle=The+role+of+EBV+in+the+pathogenesis+of+Burkitt%27s+Lymphoma%3A+an+Italian+hospital+based+survey&amp;rft.volume=9&amp;rft.issue=1&amp;rft.pages=34&amp;rft.date=2014&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4216353&amp;rft_id=info%3Apmid%2F25364378&amp;rft_id=info%3Adoi%2F10.1186%2F1750-9378-9-34&amp;rft.aulast=Pannone&amp;rft.aufirst=G&amp;rft.au=Zamparese%2C+R&amp;rft.au=Pace%2C+M&amp;rft.au=Pedicillo%2C+MC&amp;rft.au=Cagiano%2C+S&amp;rft.au=Somma%2C+P&amp;rft.au=Errico%2C+ME&amp;rft.au=Donofrio%2C+V&amp;rft.au=Franco%2C+R&amp;rft.au=De+Chiara%2C+A&amp;rft.au=Aquino%2C+G&amp;rft.au=Bucci%2C+P&amp;rft.au=Bucci%2C+E&amp;rft.au=Santoro%2C+A&amp;rft.au=Bufo%2C+P&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4216353&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-38"><span><b><a href="#cite_ref-38" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Gandhi MK, Tellam JT, Khanna R (May 2004). "Epstein-Barr virus-associated Hodgkin's lymphoma". <i>British Journal of Haematology</i>. <b>125</b> (3): 267–81. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1111%2Fj.1365-2141.2004.04902.x">10.1111/j.1365-2141.2004.04902.x</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/15086409">15086409</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Journal+of+Haematology&amp;rft.atitle=Epstein-Barr+virus-associated+Hodgkin%27s+lymphoma&amp;rft.volume=125&amp;rft.issue=3&amp;rft.pages=267-81&amp;rft.date=2004-05&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2141.2004.04902.x&amp;rft_id=info%3Apmid%2F15086409&amp;rft.aulast=Gandhi&amp;rft.aufirst=MK&amp;rft.au=Tellam%2C+JT&amp;rft.au=Khanna%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-39"><span><b><a href="#cite_ref-39" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Dogan S, Hedberg ML, Ferris RL, Rath TJ, Assaad AM, Chiosea SI (April 2014). <a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656191">"Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a low-incidence population"</a>. <i>Head &amp; Neck</i>. <b>36</b> (4): 511–6. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1002%2Fhed.23318">10.1002/hed.23318</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Central" title="PubMed Central">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656191">4656191</a></span>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/23780921">23780921</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Head+%26+Neck&amp;rft.atitle=Human+papillomavirus+and+Epstein-Barr+virus+in+nasopharyngeal+carcinoma+in+a+low-incidence+population&amp;rft.volume=36&amp;rft.issue=4&amp;rft.pages=511-6&amp;rft.date=2014-04&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4656191&amp;rft_id=info%3Apmid%2F23780921&amp;rft_id=info%3Adoi%2F10.1002%2Fhed.23318&amp;rft.aulast=Dogan&amp;rft.aufirst=S&amp;rft.au=Hedberg%2C+ML&amp;rft.au=Ferris%2C+RL&amp;rft.au=Rath%2C+TJ&amp;rft.au=Assaad%2C+AM&amp;rft.au=Chiosea%2C+SI&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4656191&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-pmid25740864-40"><span><b><a href="#cite_ref-pmid25740864_40-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Mechelli R, Manzari C, Policano C, Annese A, Picardi E, Umeton R,  et al. (March 2015). <a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388746">"Epstein-Barr virus genetic variants are associated with multiple sclerosis"</a>. <i>Neurology</i>. <b>84</b> (13): 1362–8. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1212%2FWNL.0000000000001420">10.1212/WNL.0000000000001420</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Central" title="PubMed Central">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388746">4388746</a></span>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/25740864">25740864</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Epstein-Barr+virus+genetic+variants+are+associated+with+multiple+sclerosis&amp;rft.volume=84&amp;rft.issue=13&amp;rft.pages=1362-8&amp;rft.date=2015-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4388746&amp;rft_id=info%3Apmid%2F25740864&amp;rft_id=info%3Adoi%2F10.1212%2FWNL.0000000000001420&amp;rft.aulast=Mechelli&amp;rft.aufirst=R&amp;rft.au=Manzari%2C+C&amp;rft.au=Policano%2C+C&amp;rft.au=Annese%2C+A&amp;rft.au=Picardi%2C+E&amp;rft.au=Umeton%2C+R&amp;rft.au=Fornasiero%2C+A&amp;rft.au=D%27Erchia%2C+AM&amp;rft.au=Buscarinu%2C+MC&amp;rft.au=Agliardi%2C+C&amp;rft.au=Annibali%2C+V&amp;rft.au=Serafini%2C+B&amp;rft.au=Rosicarelli%2C+B&amp;rft.au=Romano%2C+S&amp;rft.au=Angelini%2C+DF&amp;rft.au=Ricigliano%2C+VA&amp;rft.au=Buttari%2C+F&amp;rft.au=Battistini%2C+L&amp;rft.au=Centonze%2C+D&amp;rft.au=Guerini%2C+FR&amp;rft.au=D%27Alfonso%2C+S&amp;rft.au=Pesole%2C+G&amp;rft.au=Salvetti%2C+M&amp;rft.au=Ristori%2C+G&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4388746&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-41"><span><b><a href="#cite_ref-41" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Tagliavini E, Rossi G, Valli R, Zanelli M, Cadioli A, Mengoli MC,  et al. (August 2013). "Lymphomatoid granulomatosis: a practical review for pathologists dealing with this rare pulmonary lymphoproliferative process". <i>Pathologica</i>. <b>105</b> (4): 111–6. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/24466760">24466760</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pathologica&amp;rft.atitle=Lymphomatoid+granulomatosis%3A+a+practical+review+for+pathologists+dealing+with+this+rare+pulmonary+lymphoproliferative+process&amp;rft.volume=105&amp;rft.issue=4&amp;rft.pages=111-6&amp;rft.date=2013-08&amp;rft_id=info%3Apmid%2F24466760&amp;rft.aulast=Tagliavini&amp;rft.aufirst=E&amp;rft.au=Rossi%2C+G&amp;rft.au=Valli%2C+R&amp;rft.au=Zanelli%2C+M&amp;rft.au=Cadioli%2C+A&amp;rft.au=Mengoli%2C+MC&amp;rft.au=Bisagni%2C+A&amp;rft.au=Cavazza%2C+A&amp;rft.au=Gardini%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-42"><span><b><a href="#cite_ref-42" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Di Lernia V, Mansouri Y (October 2013). "Epstein-Barr virus and skin manifestations in childhood". <i>International Journal of Dermatology</i>. <b>52</b> (10): 1177–84. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1111%2Fj.1365-4632.2012.05855.x">10.1111/j.1365-4632.2012.05855.x</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/24073903">24073903</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Dermatology&amp;rft.atitle=Epstein-Barr+virus+and+skin+manifestations+in+childhood&amp;rft.volume=52&amp;rft.issue=10&amp;rft.pages=1177-84&amp;rft.date=2013-10&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-4632.2012.05855.x&amp;rft_id=info%3Apmid%2F24073903&amp;rft.aulast=Di+Lernia&amp;rft.aufirst=V&amp;rft.au=Mansouri%2C+Y&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-pmid27900557-43"><span><b><a href="#cite_ref-pmid27900557_43-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Kyriakidis I, Vasileiou E, Karastrati S, Tragiannidis A, Gompakis N, Hatzistilianou M (December 2016). "Primary EBV infection and hypersensitivity to mosquito bites: a case report". <i>Virologica Sinica</i>. <b>31</b> (6): 517–520. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1007%2Fs12250-016-3868-4">10.1007/s12250-016-3868-4</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/27900557">27900557</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Virologica+Sinica&amp;rft.atitle=Primary+EBV+infection+and+hypersensitivity+to+mosquito+bites%3A+a+case+report&amp;rft.volume=31&amp;rft.issue=6&amp;rft.pages=517-520&amp;rft.date=2016-12&amp;rft_id=info%3Adoi%2F10.1007%2Fs12250-016-3868-4&amp;rft_id=info%3Apmid%2F27900557&amp;rft.aulast=Kyriakidis&amp;rft.aufirst=I&amp;rft.au=Vasileiou%2C+E&amp;rft.au=Karastrati%2C+S&amp;rft.au=Tragiannidis%2C+A&amp;rft.au=Gompakis%2C+N&amp;rft.au=Hatzistilianou%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-44"><span><b><a href="#cite_ref-44" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Woulfe J, Hoogendoorn H, Tarnopolsky M, Muñoz DG (November 2000). "Monoclonal antibodies against Epstein-Barr virus cross-react with alpha-synuclein in human brain". <i>Neurology</i>. <b>55</b> (9): 1398–401. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1212%2FWNL.55.9.1398">10.1212/WNL.55.9.1398</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/11087792">11087792</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Monoclonal+antibodies+against+Epstein-Barr+virus+cross-react+with+alpha-synuclein+in+human+brain&amp;rft.volume=55&amp;rft.issue=9&amp;rft.pages=1398-401&amp;rft.date=2000-11&amp;rft_id=info%3Adoi%2F10.1212%2FWNL.55.9.1398&amp;rft_id=info%3Apmid%2F11087792&amp;rft.aulast=Woulfe&amp;rft.aufirst=J&amp;rft.au=Hoogendoorn%2C+H&amp;rft.au=Tarnopolsky%2C+M&amp;rft.au=Mu%C3%B1oz%2C+DG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-BBC-45"><span><b><a href="#cite_ref-BBC_45-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>McGrath P (6 April 2014). <a rel="nofollow" href="https://www.bbc.co.uk/news/health-26857610">"Cancer virus discovery helped by delayed flight"</a>. BBC News, Health. <a rel="nofollow" href="https://web.archive.org/web/20151008021944/http://www.bbc.co.uk/news/health-26857610">Archived</a> from the original on 8 October 2015<span>. Retrieved <span>4 November</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Cancer+virus+discovery+helped+by+delayed+flight&amp;rft.date=2014-04-06&amp;rft.aulast=McGrath&amp;rft.aufirst=Paula&amp;rft_id=https%3A%2F%2Fwww.bbc.co.uk%2Fnews%2Fhealth-26857610&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-46"><span><b><a href="#cite_ref-46" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Epstein MA, Achong BG, Barr YM (March 1964). "Virus Particles in Cultured Lymphoblasts from Burkitt's Lymphoma". <i>Lancet</i>. <b>1</b> (7335): 702–3. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1016%2Fs0140-6736%2864%2991524-7">10.1016/s0140-6736(64)91524-7</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/14107961">14107961</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Virus+Particles+in+Cultured+Lymphoblasts+from+Burkitt%27s+Lymphoma&amp;rft.volume=1&amp;rft.issue=7335&amp;rft.pages=702-3&amp;rft.date=1964-03&amp;rft_id=info%3Adoi%2F10.1016%2Fs0140-6736%2864%2991524-7&amp;rft_id=info%3Apmid%2F14107961&amp;rft.aulast=Epstein&amp;rft.aufirst=MA&amp;rft.au=Achong%2C+BG&amp;rft.au=Barr%2C+YM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-47"><span><b><a href="#cite_ref-47" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite><a href="https://en.wikipedia.org/wiki/M._Anthony_Epstein" title="M. Anthony Epstein">Epstein MA</a> (2005). <a rel="nofollow" href="https://books.google.com/books?id=TRO-wXto8hcC">"1. The origins of EBV research: discovery and characterization of the virus"</a>.  In Robertson ES (ed.). <i>Epstein–Barr Virus</i>. Trowbridge: Cromwell Press. pp.&nbsp;1–14. <a href="https://en.wikipedia.org/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&nbsp;<a href="https://en.wikipedia.org/wiki/Special:BookSources/978-1-904455-03-5" title="Special:BookSources/978-1-904455-03-5"><bdi>978-1-904455-03-5</bdi></a><span>. Retrieved <span>September 18,</span> 2010</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=1.+The+origins+of+EBV+research%3A+discovery+and+characterization+of+the+virus&amp;rft.btitle=Epstein%E2%80%93Barr+Virus&amp;rft.place=Trowbridge&amp;rft.pages=1-14&amp;rft.pub=Cromwell+Press&amp;rft.date=2005&amp;rft.isbn=978-1-904455-03-5&amp;rft.aulast=Epstein&amp;rft.aufirst=M.+Anthony&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DTRO-wXto8hcC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-Robertson2005-48"><span><b><a href="#cite_ref-Robertson2005_48-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Erle S. Robertson (2005). <a rel="nofollow" href="https://books.google.com/books?id=TRO-wXto8hcC"><i>Epstein–Barr Virus</i></a>. Horizon Scientific Press. p.&nbsp;18. <a href="https://en.wikipedia.org/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&nbsp;<a href="https://en.wikipedia.org/wiki/Special:BookSources/978-1-904455-03-5" title="Special:BookSources/978-1-904455-03-5"><bdi>978-1-904455-03-5</bdi></a><span>. Retrieved <span>3 June</span> 2012</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Epstein%E2%80%93Barr+Virus&amp;rft.pages=18&amp;rft.pub=Horizon+Scientific+Press&amp;rft.date=2005&amp;rft.isbn=978-1-904455-03-5&amp;rft.au=Erle+S.+Robertson&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DTRO-wXto8hcC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-49"><span><b><a href="#cite_ref-49" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Miller G (December 21, 2006). "Book Review: Epstein–Barr Virus". <i><a href="https://en.wikipedia.org/wiki/New_England_Journal_of_Medicine" title="New England Journal of Medicine">New England Journal of Medicine</a></i>. <b>355</b> (25): 2708–2709. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1056%2FNEJMbkrev39523">10.1056/NEJMbkrev39523</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.atitle=Book+Review%3A+Epstein%E2%80%93Barr+Virus&amp;rft.volume=355&amp;rft.issue=25&amp;rft.pages=2708-2709&amp;rft.date=2006-12-21&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMbkrev39523&amp;rft.aulast=Miller&amp;rft.aufirst=George&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-pmid6261650-50"><span><b><a href="#cite_ref-pmid6261650_50-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Henle W, Henle G (1980). "Epidemiologic aspects of Epstein-Barr virus (EBV)-associated diseases". <i>Annals of the New York Academy of Sciences</i>. <b>354</b>: 326–31. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1111%2Fj.1749-6632.1980.tb27975.x">10.1111/j.1749-6632.1980.tb27975.x</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/6261650">6261650</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+the+New+York+Academy+of+Sciences&amp;rft.atitle=Epidemiologic+aspects+of+Epstein-Barr+virus+%28EBV%29-associated+diseases&amp;rft.volume=354&amp;rft.pages=326-31&amp;rft.date=1980&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1749-6632.1980.tb27975.x&amp;rft_id=info%3Apmid%2F6261650&amp;rft.aulast=Henle&amp;rft.aufirst=W&amp;rft.au=Henle%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-isbn0-12-375147-0-51"><span><b><a href="#cite_ref-isbn0-12-375147-0_51-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Young, LS (2009). <i>Desk Encyclopedia of Human and Medical Virology</i>. Boston: Academic Press. pp.&nbsp;532–533.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Desk+Encyclopedia+of+Human+and+Medical+Virology&amp;rft.place=Boston&amp;rft.pages=532-533&amp;rft.pub=Academic+Press&amp;rft.date=2009&amp;rft.au=Young%2C+LS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-pmid18938248-52"><span><b><a href="#cite_ref-pmid18938248_52-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Delecluse HJ, Feederle R, Behrends U, Mautner J (December 2008). "Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus". <i>Seminars in Cancer Biology</i>. <b>18</b> (6): 409–15. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1016%2Fj.semcancer.2008.09.001">10.1016/j.semcancer.2008.09.001</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/18938248">18938248</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Seminars+in+Cancer+Biology&amp;rft.atitle=Contribution+of+viral+recombinants+to+the+study+of+the+immune+response+against+the+Epstein-Barr+virus&amp;rft.volume=18&amp;rft.issue=6&amp;rft.pages=409-15&amp;rft.date=2008-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.semcancer.2008.09.001&amp;rft_id=info%3Apmid%2F18938248&amp;rft.aulast=Delecluse&amp;rft.aufirst=HJ&amp;rft.au=Feederle%2C+R&amp;rft.au=Behrends%2C+U&amp;rft.au=Mautner%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-pmid22901543-53"><span><b><a href="#cite_ref-pmid22901543_53-0" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Arvey A, Tempera I, Tsai K, Chen HS, Tikhmyanova N, Klichinsky M,  et al. (August 2012). <a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424516">"An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions"</a>. <i>Cell Host &amp; Microbe</i>. <b>12</b> (2): 233–45. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1016%2Fj.chom.2012.06.008">10.1016/j.chom.2012.06.008</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Central" title="PubMed Central">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424516">3424516</a></span>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/22901543">22901543</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell+Host+%26+Microbe&amp;rft.atitle=An+atlas+of+the+Epstein-Barr+virus+transcriptome+and+epigenome+reveals+host-virus+regulatory+interactions&amp;rft.volume=12&amp;rft.issue=2&amp;rft.pages=233-45&amp;rft.date=2012-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3424516&amp;rft_id=info%3Apmid%2F22901543&amp;rft_id=info%3Adoi%2F10.1016%2Fj.chom.2012.06.008&amp;rft.aulast=Arvey&amp;rft.aufirst=A&amp;rft.au=Tempera%2C+I&amp;rft.au=Tsai%2C+K&amp;rft.au=Chen%2C+HS&amp;rft.au=Tikhmyanova%2C+N&amp;rft.au=Klichinsky%2C+M&amp;rft.au=Leslie%2C+C&amp;rft.au=Lieberman%2C+PM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3424516&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
<li id="cite_note-54"><span><b><a href="#cite_ref-54" aria-label="Jump up" title="Jump up">^</a></b></span> <span><cite>Hoshino Y, Katano H, Zou P, Hohman P, Marques A, Tyring SK,  et al. (November 2009). <a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2772668">"Long-term administration of valacyclovir reduces the number of Epstein-Barr virus (EBV)-infected B cells but not the number of EBV DNA copies per B cell in healthy volunteers"</a>. <i>Journal of Virology</i>. <b>83</b> (22): 11857–61. <a href="https://en.wikipedia.org/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" href="https://doi.org/10.1128%2FJVI.01005-09">10.1128/JVI.01005-09</a>. <a href="https://en.wikipedia.org/wiki/PubMed_Central" title="PubMed Central">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2772668">2772668</a></span>. <a href="https://en.wikipedia.org/wiki/PubMed_Identifier" title="PubMed Identifier">PMID</a>&nbsp;<a rel="nofollow" href="https://pubmed.ncbi.nlm.nih.gov/19740997">19740997</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Virology&amp;rft.atitle=Long-term+administration+of+valacyclovir+reduces+the+number+of+Epstein-Barr+virus+%28EBV%29-infected+B+cells+but+not+the+number+of+EBV+DNA+copies+per+B+cell+in+healthy+volunteers&amp;rft.volume=83&amp;rft.issue=22&amp;rft.pages=11857-61&amp;rft.date=2009-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2772668&amp;rft_id=info%3Apmid%2F19740997&amp;rft_id=info%3Adoi%2F10.1128%2FJVI.01005-09&amp;rft.aulast=Hoshino&amp;rft.aufirst=Y&amp;rft.au=Katano%2C+H&amp;rft.au=Zou%2C+P&amp;rft.au=Hohman%2C+P&amp;rft.au=Marques%2C+A&amp;rft.au=Tyring%2C+SK&amp;rft.au=Follmann%2C+D&amp;rft.au=Cohen%2C+JI&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2772668&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpstein%E2%80%93Barr+virus"></span></span>
</li>
</ol></div>
<h2><span id="External_links">External links</span><span><span>[</span><a href="https://en.wikipedia.org/w/index.php?title=Epstein%E2%80%93Barr_virus&amp;action=edit&amp;section=19" title="Edit section: External links">edit</a><span>]</span></span></h2>
<ul><li><a rel="nofollow" href="http://ebv.wistar.upenn.edu/">Transcriptome and epigenome of EBV</a></li></ul>
<h2><span id="External_links_2">External links</span><span><span>[</span><a href="https://en.wikipedia.org/w/index.php?title=Epstein%E2%80%93Barr_virus&amp;action=edit&amp;section=20" title="Edit section: External links">edit</a><span>]</span></span></h2>




<!-- 
NewPP limit report
Parsed by mw1264
Cached time: 20200215150029
Cache expiry: 2592000
Dynamic content: false
Complications: [vary‐revision‐sha1]
CPU time usage: 1.320 seconds
Real time usage: 1.627 seconds
Preprocessor visited node count: 6085/1000000
Post‐expand include size: 293474/2097152 bytes
Template argument size: 4315/2097152 bytes
Highest expansion depth: 17/40
Expensive parser function count: 10/500
Unstrip recursion depth: 1/20
Unstrip post‐expand size: 199390/5000000 bytes
Number of Wikibase entities loaded: 8/400
Lua time usage: 0.827/10.000 seconds
Lua memory usage: 7.89 MB/50 MB
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00% 1364.607      1 -total
 46.98%  641.138      1 Template:Reflist
 28.84%  393.513     42 Template:Cite_journal
 15.55%  212.246      1 Template:Virusbox
  9.25%  126.226      6 Template:Cite_web
  7.96%  108.604      1 Template:Taxonbar
  6.33%   86.431     13 Template:Navbox
  6.10%   83.204      1 Template:Herpesvirales
  5.72%   78.050      1 Template:Navbox_with_collapsible_groups
  4.14%   56.464      2 Template:Citation_needed
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:214550-0!canonical and timestamp 20200215150028 and revision id 938214397
 -->
</div></div></div></div>
    </div>
    <footer>
        <div>created by buildstarted &copy; 2020 <a href="/about">about</a></div>
        <div>Share this page on social media: copy and paste this url https://linksfor.dev/</div>
        <div>If you prefer RSS: <a href="https://linksfor.dev/feed.xml">https://linksfor.dev/feed.xml</a></div>
        <div>Customer satisfaction guaranteed to be optional.</div>
    </footer>
    
    <script async defer>
        _dna = window._dna || {};
        _dna.siteId = "linksfor.devs";
        _dna.outlink = true;

        (function () {
            let dna = document.createElement('script');
            dna.type = 'text/javascript';
            dna.async = true;
            dna.src = '//dna.buildstarted.com/t.js';
            let s = document.getElementsByTagName('script')[0];
            s.parentNode.insertBefore(dna, s);
        })();
    </script>
    <noscript><img src="//dna.buildstarted.com/g?siteId=linksfor.devs" /></noscript>
</body>
</html>